<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:49:02Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10289422" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10289422</identifier>
        <datestamp>2023-06-24</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLOS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10289422</article-id>
              <article-id pub-id-type="pmcid">PMC10289422</article-id>
              <article-id pub-id-type="pmc-uid">10289422</article-id>
              <article-id pub-id-type="pmid">37352296</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0287525</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-22-25924</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Public and occupational health</subject>
                    <subj-group>
                      <subject>Preventive medicine</subject>
                      <subj-group>
                        <subject>HIV prevention</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Public and Occupational Health</subject>
                    <subj-group>
                      <subject>Preventive Medicine</subject>
                      <subj-group>
                        <subject>Prophylaxis</subject>
                        <subj-group>
                          <subject>Pre-Exposure Prophylaxis</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical Microbiology</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Immunodeficiency Viruses</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pathology and Laboratory Medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Immunodeficiency Viruses</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral Pathogens</subject>
                        <subj-group>
                          <subject>Immunodeficiency Viruses</subject>
                          <subj-group>
                            <subject>HIV</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Immunodeficiency Viruses</subject>
                        <subj-group>
                          <subject>HIV</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>RNA viruses</subject>
                        <subj-group>
                          <subject>Retroviruses</subject>
                          <subj-group>
                            <subject>Lentivirus</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical Microbiology</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Retroviruses</subject>
                            <subj-group>
                              <subject>Lentivirus</subject>
                              <subj-group>
                                <subject>HIV</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pathology and Laboratory Medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Retroviruses</subject>
                            <subj-group>
                              <subject>Lentivirus</subject>
                              <subj-group>
                                <subject>HIV</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral Pathogens</subject>
                        <subj-group>
                          <subject>Retroviruses</subject>
                          <subj-group>
                            <subject>Lentivirus</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Sociology</subject>
                    <subj-group>
                      <subject>Education</subject>
                      <subj-group>
                        <subject>Schools</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>HIV epidemiology</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Mental Health and Psychiatry</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Medical Risk Factors</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Mental Health and Psychiatry</subject>
                    <subj-group>
                      <subject>Mood Disorders</subject>
                      <subj-group>
                        <subject>Depression</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study)</article-title>
                <alt-title alt-title-type="running-head">Preferences for Oral Pre-exposure Prophylaxis (PrEP) or Dapivirine Intravaginal Ring</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Ngure</surname>
                    <given-names>Kenneth</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Friedland</surname>
                    <given-names>Barbara A.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Szydlo</surname>
                    <given-names>Daniel W.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3318-9781</contrib-id>
                  <name>
                    <surname>Roberts</surname>
                    <given-names>Sarah T.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Garcia</surname>
                    <given-names>Morgan</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Levy</surname>
                    <given-names>Lisa</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Akello</surname>
                    <given-names>Carolyne A.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Reddy</surname>
                    <given-names>Krishnaveni</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Palanee-Phillips</surname>
                    <given-names>Thesla</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Macdonald</surname>
                    <given-names>Pippa</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Siziba</surname>
                    <given-names>Bekezela</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Soto-Torres</surname>
                    <given-names>Lydia</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hosek</surname>
                    <given-names>Sybil</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff011" ref-type="aff">
                    <sup>11</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hillier</surname>
                    <given-names>Sharon L.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff012" ref-type="aff">
                    <sup>12</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nair</surname>
                    <given-names>Gonasagrie</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff013" ref-type="aff">
                    <sup>13</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Celum</surname>
                    <given-names>Connie</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="aff014" ref-type="aff">
                    <sup>14</sup>
                  </xref>
                  <xref rid="aff015" ref-type="aff">
                    <sup>15</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>van der Straten</surname>
                    <given-names>Ariane</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff016" ref-type="aff">
                    <sup>16</sup>
                  </xref>
                  <xref rid="aff017" ref-type="aff">
                    <sup>17</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>School of Public Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Global Health, University of Washington, Seattle, WA, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Population Council, Center for Biomedical Research, New York, NY, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Women’s Global Health Imperative (WGHI), RTI International, Berkeley, California, United States of America</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>FHI 360, Durham, North Carolina, United States of America</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>Johns Hopkins University Research Collaboration, Makerere University, Kampala, Uganda</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America</addr-line>
              </aff>
              <aff id="aff011">
                <label>11</label>
                <addr-line>Department of Psychiatry, John Stroger Hospital of Cook County, Chicago, Illinois, United States of America</addr-line>
              </aff>
              <aff id="aff012">
                <label>12</label>
                <addr-line>Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America</addr-line>
              </aff>
              <aff id="aff013">
                <label>13</label>
                <addr-line>Centre for Medical Ethics and Law, Stellenbosch University, Stellenbosch, South Africa</addr-line>
              </aff>
              <aff id="aff014">
                <label>14</label>
                <addr-line>Department of Medicine, University of Washington, Seattle, Washington, United States of America</addr-line>
              </aff>
              <aff id="aff015">
                <label>15</label>
                <addr-line>Department of Epidemiology University of Washington, Seattle, Washington, United States of America</addr-line>
              </aff>
              <aff id="aff016">
                <label>16</label>
                <addr-line>Center for AIDS Prevention Studies, Dept of Medicine, University of California, San Francisco, San Francisco, California, United States of America</addr-line>
              </aff>
              <aff id="aff017">
                <label>17</label>
                <addr-line>ASTRA Consulting, Kensington, CA, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Francis</surname>
                    <given-names>Joel Msafiri</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>University of the Witwatersrand, SOUTH AFRICA</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>kngure@jkuat.ac.ke</email>, <email>kngure@uw.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>23</day>
                <month>6</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>18</volume>
              <issue>6</issue>
              <elocation-id>e0287525</elocation-id>
              <history>
                <date date-type="received">
                  <day>21</day>
                  <month>9</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>7</day>
                  <month>6</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 Ngure et al</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Ngure et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0287525.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Introduction</title>
                  <p>Adolescent girls and young women (AGYW) in sub-Saharan Africa are disproportionately affected by the HIV epidemic and face an array of challenges using proven behavioral and biomedical prevention methods. To address the urgent need for expanding prevention options, we evaluated the baseline preferences of HIV prevention methods among participants enrolled in the MTN-034/REACH crossover trial along with their stated product preference prior to product initiation.</p>
                </sec>
                <sec id="sec002">
                  <title>Methods</title>
                  <p>AGYW aged 16–21 years were enrolled at 4 study sites: Cape Town and Johannesburg, South Africa; Kampala, Uganda; and Harare, Zimbabwe and randomly assigned to the sequence of using oral PrEP and the dapivirine ring for 6 months each, followed by a choice period in which they could choose either product (or neither) for an additional six months. Eligible AGYW were HIV-negative, not pregnant and using effective contraception for at least two months prior to enrollment. Descriptive statistics were used to summarize demographic and behavioral data while multinomial analysis was used to determine predictors of stated product preference (ring or oral PrEP).</p>
                </sec>
                <sec id="sec003">
                  <title>Results</title>
                  <p>Of the 247 AGYW enrolled in REACH, 34% were aged 16–17 and 89% had a primary partner.The median age of sexual debut was 16 years and 40% had ever been pregnant. At screening, 35% of participants were diagnosed with a sexually transmitted infection (STI), 39% had an AUDIT-C score associated with harmful drinking and 11% reported intimate partner violence in the past 6 months. Overall, 28% of participants, had CESD-10 scores suggestive of depressive symptoms (≥12) in the past week. At baseline, similar proportions stated a preference for the ring and oral PrEP (38.1% and 40.5% respectively), with 19% of participants stating they preferred both products equally. Only study site was significantly associated with product preference (P&lt;0.05) with AGYW from Johannesburg having higher odds of preferring the ring and those from Kampala having higher odds of preferring both options equally.</p>
                </sec>
                <sec id="sec004">
                  <title>Conclusions</title>
                  <p>We successfully enrolled African AGYW with a clear unmet need for HIV prevention. The balanced preference between the two products suggests that multiple biomedical prevention options may be appealing to this age group and could address their prevention needs.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
                      <institution>National Institute of Allergy and Infectious Diseases</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>UM1AI068633,UM1AI068615,UM1AI106707</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Hillier</surname>
                      <given-names>Sharon L.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100009633</institution-id>
                      <institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution>
                    </institution-wrap>
                  </funding-source>
                  <principal-award-recipient>
                    <name>
                      <surname>Hillier</surname>
                      <given-names>Sharon L.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000025</institution-id>
                      <institution>National Institute of Mental Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <principal-award-recipient>
                    <name>
                      <surname>Hillier</surname>
                      <given-names>Sharon L.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution>National Institute of Health (NIH)</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <name>
                      <surname>Hillier</surname>
                      <given-names>Sharon L.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>The study was designed and implemented by the Microbicide Trials Network (MTN) and was funded by the National Institute of Allergy and Infectious Diseases through individual grants (UM1AI068633, UM1AI068615 and UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="1"/>
                <table-count count="4"/>
                <page-count count="17"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Data cannot be shared publicly because the primary manuscript of the trial has not been published. Data are available from the Microbicides Trials Network Institutional Data Access / Ethics Committee (contact via <email>mtn034leadership@mtnstopshiv.org</email>) for researchers who meet the criteria for access to confidential data.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Data cannot be shared publicly because the primary manuscript of the trial has not been published. Data are available from the Microbicides Trials Network Institutional Data Access / Ethics Committee (contact via <email>mtn034leadership@mtnstopshiv.org</email>) for researchers who meet the criteria for access to confidential data.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec005">
              <title>Introduction</title>
              <p>In sub-Saharan Africa, adolescent girls, and young women (AGYW) aged 15–24 years old are disproportionately affected by the HIV epidemic, with the majority of new infections in 15–19-year-olds occurring among females [<xref rid="pone.0287525.ref001" ref-type="bibr">1</xref>]. HIV continues to be the leading cause of death among 10–19-year-olds in Africa and the second most common cause of death among adolescents globally [<xref rid="pone.0287525.ref002" ref-type="bibr">2</xref>]. An array of factors contribute to AGYW’s HIV risk, including lack of awareness regarding safe sexual practices, inability to negotiate male condom use, biological development, and lack of psychosexual maturation [<xref rid="pone.0287525.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0287525.ref004" ref-type="bibr">4</xref>]. These factors impede AGYW’s use of proven behavioral and biomedical HIV prevention methods and highlight the urgent need to expand options available to young African women.</p>
              <p>Truvada® (emtricitabine [FTC] and tenofovir disoproxil fumarate [TDF]) used once daily for oral pre-exposure prophylaxis (PrEP) has been a cornerstone of HIV prevention efforts since its approval by the US Food and Drug Administration (FDA) in 2012 [<xref rid="pone.0287525.ref005" ref-type="bibr">5</xref>]. The World Health Organization (WHO) recommended offering oral PrEP to select key populations at high risk of HIV acquisition in 2014 [<xref rid="pone.0287525.ref006" ref-type="bibr">6</xref>], and subsequently expanded their recommendations for broader provision based on evidence that itis safe, cost-effective, and highly efficacious in reducing HIV acquisition regardless of age, gender, or mode of transmission [<xref rid="pone.0287525.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0287525.ref008" ref-type="bibr">8</xref>]. However, challenges with daily pill use and low persistence, especially among AGYW [<xref rid="pone.0287525.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0287525.ref010" ref-type="bibr">10</xref>] indicate that some young women who could benefit from daily oral PrEP do not choose to or are unable to use it consistently.</p>
              <p>A one-month intravaginal ring containing the antiretroviral drug dapivirine (ring) was shown to reduce the risk of HIV-1 acquisition by approximately 30% in two Phase 3 trials among healthy female adults in sub-Saharan Africa [<xref rid="pone.0287525.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0287525.ref012" ref-type="bibr">12</xref>]. The ring was recently approved by the European Medicines Agency (EMA) and has been recommended by the WHO as a prevention option for women who are unwilling or unable to use oral PrEP [<xref rid="pone.0287525.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0287525.ref014" ref-type="bibr">14</xref>]. In post-hoc analyses for both studies, greater risk reduction (up to 75%) was observed among participants with higher ring adherence [<xref rid="pone.0287525.ref015" ref-type="bibr">15</xref>]. The ring is a promising alternative to oral PrEP; however, data are needed to determine if the ring can successfully address challenges to oral PrEP adherence. Furthermore, there is a need for more data on how 16–17 year-old AGYW in sub-Saharan Africa will use the ring, since it has not yet been studied in that population.</p>
              <p>To that end, the Microbicide Trials Network (MTN) implemented MTN-034/REACH (Reversing the Epidemic in Africa with Choices in HIV Prevention)to evaluate the safety, adherence, acceptability, and preference of the ring versus oral PrEP. Here we report on the baseline characteristics and pre-use product preferences of participants enrolled in the trial</p>
            </sec>
            <sec sec-type="materials|methods" id="sec006">
              <title>Methods</title>
              <sec id="sec007">
                <title>Study design</title>
                <p>REACH was a multi-site, two-arm, randomized, open-label, crossover Phase 2a trial (ClinicalTrials.gov: NCT03593655) that aimed to enroll ˜300 participants across four sites in Africa (Kampala, Uganda; Harare, Zimbabwe; and Cape Town and Johannesburg, South Africa). Participants were randomized (1:1) to one of two sequences of product use: using the ring for 24 weeks and then switching to oral PrEP for a second 24 weeks or using oral PrEP for 24 weeks and then switching to the ring (<xref rid="pone.0287525.g001" ref-type="fig">Fig 1</xref>). After completing the crossover period, participants could choose oral PrEP, the ring, or neither to use in 24-week Choice period.</p>
                <fig position="float" id="pone.0287525.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0287525.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>REACH study design and visit schedule.</title>
                  </caption>
                  <graphic xlink:href="pone.0287525.g001" position="float"/>
                </fig>
              </sec>
              <sec id="sec008">
                <title>Study population and baseline testing prior to enrollment</title>
                <p>Eligible participants were 16–21 years of age, HIV-negative per rapid test at screening and enrollment, not pregnant at screening or enrollment, using effective contraception for at least two months prior to enrollment (for those not on contraceptive at screening, the study offered effective contraception at screening, encouraging long-acting contraceptives), and healthy based on physical exam, pelvic exam and laboratory testing. Pregnancy and breastfeeding were exclusionary because the ring had not yet been studied in in an African population of this age. There were no other criteria related to sexual behavior or HIV vulnerability.</p>
              </sec>
              <sec id="sec009">
                <title>Recruitment</title>
                <p>Participants were recruited from a variety of settings including, but not limited to, adolescent and primary care health clinics, family planning clinics, HIV testing facilities, gynecology clinics, institutions of higher learning, community-based youth centers, schools, and other community locations. Community education strategies, including use of pelvic models to demonstrate ring insertion, an educational video, and other printed materials were shared individually and in group sessions and via social media platforms to inform potential participants and parents/guardians about the study. Although the study was designed to enroll approximately 300 participants, screening and enrollment on all MTN studies was paused on March 28, 2020, due to the COVID-19 pandemic and its impact on research operations. Because the study had reached 82% of its accrual target, the study was not reopened for screening and enrollment. Therefore, a total of 247 were enrolled in the study. It was a requirement that at least a third of enrolled participants were aged 16–17 to provide important safety data in this age group. In Uganda, because recruitment of minors from schools was prohibited by the local IRB, emancipated minors from the community, including school dropouts, were targeted. All recruitment materials were approved by sites’ IRBs/Ethics Committees (ECs) prior to use.</p>
              </sec>
              <sec id="sec010">
                <title>Measures</title>
                <p>Mental health conditions, especially depression and alcohol abuse, have been shown to predict PrEP adherence in multiple studies [<xref rid="pone.0287525.ref016" ref-type="bibr">16</xref>]. To explore the connection between mental health and adherence in this population, we assessed participants’ mental health at baseline using several scales administered through audio computer-assisted self-interviewing (ACASI). Participants who reported mental-health related challenges were counseled by study staff or referred to community organizations offering mental health, substance use, gender-based violence, and other services. We used the 10-item Center for Epidemiological Studies–Depression scale (CES-D-10) a short self-report questionnaire to screen for depressive symptoms in the past week [<xref rid="pone.0287525.ref017" ref-type="bibr">17</xref>]. Options for each item, such as “I feel lonely,” ranged from 0 (rarely or none of the time) to 3 (all the time). Total scores range from 0 to 30, with higher scores suggestive of a greater severity of depressive symptoms. Although Andersen determined that a score of 10 was an optimal cut-off for individuals at risk of depression [<xref rid="pone.0287525.ref017" ref-type="bibr">17</xref>], a study validating the CES-D-10 in South Africa determined that slightly higher cut-offs ranging (11,12, and 13 for Afrikaans, Zulu and Xhosa respectively) were more predictive of depressive symptoms in this population [<xref rid="pone.0287525.ref018" ref-type="bibr">18</xref>], leading us to use a score of &gt; = 12 to be indicative of depressive symptoms in our study population.</p>
                <p>Alcohol use disorders were assessed using the Alcohol Use Disorders Identification Test (AUDIT-C), a 3-item questionnaire (range 0–12). Higher scores are indicative of more harmful alcohol practices [<xref rid="pone.0287525.ref019" ref-type="bibr">19</xref>]. In women, a score of ≥3 is indicative of an alcohol abuse disorder.</p>
                <p>We used an abbreviated version Brief Self-Control Scale (BSCS) [<xref rid="pone.0287525.ref020" ref-type="bibr">20</xref>] to measure level of perceived self-control to explore associations between self-control and adherence. Each of the seven items in the scale, such as “I am good at resisting temptation” are scored from 1 (not at all) to 5 (very much). Total scores range from 7 to 35, with higher scores indicative of higher levels of self-control.</p>
                <p>Social support was assessed using the Multidimensional Scale of Perceived Social Support (MSPSS) [<xref rid="pone.0287525.ref021" ref-type="bibr">21</xref>], which has been validated in Uganda [<xref rid="pone.0287525.ref022" ref-type="bibr">22</xref>] and South Africa [<xref rid="pone.0287525.ref023" ref-type="bibr">23</xref>]. Each of the four items in the peer sub-scale (such as “My friends really try to help me”) is scored on a 5-point Likert scale from 1 (Strongly Disagree) to 5 (Strongly Agree). The overall score ranges from 1 to 20, with higher scores indicative of greater peer social support.</p>
                <p>Participants were tested for C<italic toggle="yes">hlamydia trachomatis</italic> (CT) and <italic toggle="yes">Neisseria gonorrhoeae</italic> (GC) by nucleic acid amplification testing, <italic toggle="yes">Trichomonas vaginalis</italic> (TV) by rapid test, and syphilis by rapid plasma reagin followed by a treponemal-specific confirmatory assay. AGYW with positive STI test results received treatment and were eligible to enroll once symptoms resolved to ensure they had no genital inflammation before starting ring use.</p>
              </sec>
              <sec id="sec011">
                <title>Data collection and analysis</title>
                <p>Baseline demographics and clinical data were collected via interviewer-administered case report forms (CRFs) at both the screening and enrollment visits, while baseline behavioral data were self-reported by participants via audio computer-assisted self-interviewing (ACASI) at enrollment. Medians were used to summarize the mental health scales. We explored significant associations (p &lt; 0.05) between demographic and behavioral characteristics and participants’ baseline product preferences for oral PrEP, the ring, or both products equally using multinomial logistic regression models, with “preference for oral PrEP” as the reference group. The model for site was adjusted for age (16–17-year-olds vs 18–21-year-olds), conversely, the model for age was adjusted for site, and all other models were adjusted for age and site. Analyses were carried out in SAS Version 9.4 (SAS Institute, Cary, NC, USA).</p>
              </sec>
              <sec id="sec012">
                <title>Ethics statement</title>
                <p>The study was approved by site Institutional Review Boards/Ethics Committees (IRBs/ECs) prior to use: University of Cape Town Faculty of Health Sciences Human Research Ethics Committee, University of Witwatersrand Human Research Ethics Committee, University of Zimbabwe Joint Research Ethics Committee, Johns Hopkins Medicine Institutional Review Board and the Joint Clinical AIDS Research Center IRB of Uganda. Written informed consent was obtained from adult participants, and from minors who were legally able to consent as per local regulations. Written informed assent and parental/guardian consent was obtained from all other minors, and those who turned 18 during the study subsequently signed the adult informed consent form (ICF). In addition to ICFs, the REACH Protocol Team worked with study staff and community representatives to develop appropriate materials about the study and a standardized approach to implementing the informed assent/consent process at all study sites.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec013">
              <title>Results</title>
              <p>Between February 2019 and March 2020, 247 AGYW were enrolled in REACH. Participants were median age of 18 years (interquartile range [IQR] 17,19) and most (87%) were unmarried, however other background characteristics varied substantially by site (such as self-earned income, who participants lived with, and alcohol use). About one-third (37%) of participants were currently attending either secondary or tertiary schools. The highest level of education attained by participants was secondary school and above (86%), except in Kampala, where approximately one-third of participants had attended secondary school and about half had only attended primary school. The percentage of participants who earned their own income varied considerably by site, from 3% in Cape Town to 52% in Kampala(<xref rid="pone.0287525.t001" ref-type="table">Table 1</xref>).</p>
              <table-wrap position="float" id="pone.0287525.t001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0287525.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>Baseline socio-demographic characteristics of AGYW enrolled in the REACH study (n = 247).</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0287525.t001" id="pone.0287525.t001g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1">Characteristic</th>
                        <th align="center" rowspan="1" colspan="1">SA ‐ Cape Town</th>
                        <th align="center" rowspan="1" colspan="1">SA–Johannesburg</th>
                        <th align="center" rowspan="1" colspan="1">Uganda–Kampala</th>
                        <th align="center" rowspan="1" colspan="1">Zimbabwe–Harare</th>
                        <th align="center" rowspan="1" colspan="1">All Sites</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">
                          <bold>Participants Enrolled</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">60</td>
                        <td align="center" rowspan="1" colspan="1">67</td>
                        <td align="center" rowspan="1" colspan="1">60</td>
                        <td align="center" rowspan="1" colspan="1">60</td>
                        <td align="center" rowspan="1" colspan="1">247</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Age (Median [IQR])</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">18 (17,19)</td>
                        <td align="center" rowspan="1" colspan="1">18 (17,19)</td>
                        <td align="center" rowspan="1" colspan="1">18 (17,19)</td>
                        <td align="center" rowspan="1" colspan="1">18 (17,19)</td>
                        <td align="center" rowspan="1" colspan="1">18 (17,19)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Minors (16–17)</td>
                        <td align="center" rowspan="1" colspan="1">18(30.0%)</td>
                        <td align="center" rowspan="1" colspan="1">28(47.0%)</td>
                        <td align="center" rowspan="1" colspan="1">19(28.0%)</td>
                        <td align="center" rowspan="1" colspan="1">20(33.0%)</td>
                        <td align="center" rowspan="1" colspan="1">86(34.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="6" rowspan="1">
                          <bold>Marital Status</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Single</td>
                        <td align="center" rowspan="1" colspan="1">60 (100.0%)</td>
                        <td align="center" rowspan="1" colspan="1">65(97.0%)</td>
                        <td align="center" rowspan="1" colspan="1">53(88.0%)</td>
                        <td align="center" rowspan="1" colspan="1">36(60.0%)</td>
                        <td align="center" rowspan="1" colspan="1">214(87.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Married/Cohabiting</td>
                        <td align="center" rowspan="1" colspan="1">0(0%)</td>
                        <td align="center" rowspan="1" colspan="1">2(3.0%)</td>
                        <td align="center" rowspan="1" colspan="1">7(12.0%)</td>
                        <td align="center" rowspan="1" colspan="1">21(35.0%)</td>
                        <td align="center" rowspan="1" colspan="1">30(12.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Separated or divorced</td>
                        <td align="center" rowspan="1" colspan="1">0(0%)</td>
                        <td align="center" rowspan="1" colspan="1">0(0%)</td>
                        <td align="center" rowspan="1" colspan="1">0(0%)</td>
                        <td align="center" rowspan="1" colspan="1">3(5%)</td>
                        <td align="center" rowspan="1" colspan="1">3(1%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Currently attending school</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">33(55.0%)</td>
                        <td align="center" rowspan="1" colspan="1">36(54.0%)</td>
                        <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                        <td align="center" rowspan="1" colspan="1">14(23.0%)</td>
                        <td align="center" rowspan="1" colspan="1">92(37.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="6" rowspan="1">
                          <bold>Highest Level of School Attended</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Primary</td>
                        <td align="center" rowspan="1" colspan="1">1(2.0%)</td>
                        <td align="center" rowspan="1" colspan="1">0(0.0%)</td>
                        <td align="center" rowspan="1" colspan="1">28(47.0%)</td>
                        <td align="center" rowspan="1" colspan="1">4(7.0%)</td>
                        <td align="center" rowspan="1" colspan="1">33(13.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Secondary</td>
                        <td align="center" rowspan="1" colspan="1">55(92.0%)</td>
                        <td align="center" rowspan="1" colspan="1">57(85.0%)</td>
                        <td align="center" rowspan="1" colspan="1">22(37.0%)</td>
                        <td align="center" rowspan="1" colspan="1">55(93.0%)</td>
                        <td align="center" rowspan="1" colspan="1">189(77.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Higher (e.g., college or university)</td>
                        <td align="center" rowspan="1" colspan="1">4(7.0%)</td>
                        <td align="center" rowspan="1" colspan="1">10(15.0%)</td>
                        <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                        <td align="center" rowspan="1" colspan="1">0(0.0%)</td>
                        <td align="center" rowspan="1" colspan="1">23(9.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Earns own income</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">2(3.0%)</td>
                        <td align="center" rowspan="1" colspan="1">6(9.0%)</td>
                        <td align="center" rowspan="1" colspan="1">31(52.0%)</td>
                        <td align="center" rowspan="1" colspan="1">14(23.0%)</td>
                        <td align="center" rowspan="1" colspan="1">53(21.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Has a regular place to store her things</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">43(71.7%)</td>
                        <td align="center" rowspan="1" colspan="1">60(89.6%)</td>
                        <td align="center" rowspan="1" colspan="1">52(86.7%)</td>
                        <td align="center" rowspan="1" colspan="1">48(80.0%)</td>
                        <td align="center" rowspan="1" colspan="1">203(82.2%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Who participant lives with</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Alone</td>
                        <td align="center" rowspan="1" colspan="1">0.0</td>
                        <td align="center" rowspan="1" colspan="1">1(2.0%)</td>
                        <td align="center" rowspan="1" colspan="1">6(11.0%)</td>
                        <td align="center" rowspan="1" colspan="1">2(4.0%)</td>
                        <td align="center" rowspan="1" colspan="1">9(4.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Parents</td>
                        <td align="center" rowspan="1" colspan="1">47 (78.0%)</td>
                        <td align="center" rowspan="1" colspan="1">48 (75.0%)</td>
                        <td align="center" rowspan="1" colspan="1">29 (54.0%)</td>
                        <td align="center" rowspan="1" colspan="1">32 (70.0%)</td>
                        <td align="center" rowspan="1" colspan="1">156 (70.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Lives with non-parent family members</td>
                        <td align="center" rowspan="1" colspan="1">6 (10.0%)</td>
                        <td align="center" rowspan="1" colspan="1">10 (16.0%)</td>
                        <td align="center" rowspan="1" colspan="1">16 (30.0%)</td>
                        <td align="center" rowspan="1" colspan="1">8 (17.0%)</td>
                        <td align="center" rowspan="1" colspan="1">40 (18.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Lives with non-family members</td>
                        <td align="center" rowspan="1" colspan="1">7(12.0%)</td>
                        <td align="center" rowspan="1" colspan="1">5(8.0%)</td>
                        <td align="center" rowspan="1" colspan="1">3(6.0%)</td>
                        <td align="center" rowspan="1" colspan="1">4(9.0%)</td>
                        <td align="center" rowspan="1" colspan="1">19(8.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="6" rowspan="1">
                          <bold>Worry about not getting enough food in the last 30 days</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Never</td>
                        <td align="center" rowspan="1" colspan="1">26(43.3%)</td>
                        <td align="center" rowspan="1" colspan="1">26(38.8%)</td>
                        <td align="center" rowspan="1" colspan="1">31(51.7%)</td>
                        <td align="center" rowspan="1" colspan="1">32(53.3%)</td>
                        <td align="center" rowspan="1" colspan="1">115(46.6%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Rarely + sometimes</td>
                        <td align="center" rowspan="1" colspan="1">30(50.0%)</td>
                        <td align="center" rowspan="1" colspan="1">33(49.3%)</td>
                        <td align="center" rowspan="1" colspan="1">21(35.0%)</td>
                        <td align="center" rowspan="1" colspan="1">33(38.3%)</td>
                        <td align="center" rowspan="1" colspan="1">107(43.3%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Often (more than 10 times)</td>
                        <td align="center" rowspan="1" colspan="1">4(6.7%)</td>
                        <td align="center" rowspan="1" colspan="1">8(11.9%)</td>
                        <td align="center" rowspan="1" colspan="1">8(13.3%)</td>
                        <td align="center" rowspan="1" colspan="1">5(8.3%)</td>
                        <td align="center" rowspan="1" colspan="1">25(10.1%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Median age of sexual debut (Min, Max)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">16.0 (13, 18)</td>
                        <td align="center" rowspan="1" colspan="1">16.0 (13,19)</td>
                        <td align="center" rowspan="1" colspan="1">15.0 (12,18)</td>
                        <td align="center" rowspan="1" colspan="1">16.0 (13,18)</td>
                        <td align="center" rowspan="1" colspan="1">16.0 (12,19)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Median age of first use of contraception (min, Max)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">16.0 (13,19)</td>
                        <td align="center" rowspan="1" colspan="1">17.0 (14,21)</td>
                        <td align="center" rowspan="1" colspan="1">17.5 (15,20)</td>
                        <td align="center" rowspan="1" colspan="1">17.0 (15,20)</td>
                        <td align="center" rowspan="1" colspan="1">17.0 (13,21)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="6" rowspan="1">
                          <bold>Contraceptive Method at Baseline</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Implants</td>
                        <td align="center" rowspan="1" colspan="1">11(18.3%)</td>
                        <td align="center" rowspan="1" colspan="1">30(44.8%)</td>
                        <td align="center" rowspan="1" colspan="1">37(61.7%)</td>
                        <td align="center" rowspan="1" colspan="1">33(55.0%)</td>
                        <td align="center" rowspan="1" colspan="1">111(44.9%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Copper IUD</td>
                        <td align="center" rowspan="1" colspan="1">1(1.7%)</td>
                        <td align="center" rowspan="1" colspan="1">8(11.9%) <xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                        <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                        <td align="center" rowspan="1" colspan="1">27(10.9%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Injectable contraceptive</td>
                        <td align="center" rowspan="1" colspan="1">48(80.0%)</td>
                        <td align="center" rowspan="1" colspan="1">29 (43.3%)</td>
                        <td align="center" rowspan="1" colspan="1">14(23.3%)</td>
                        <td align="center" rowspan="1" colspan="1">18(30.0%)</td>
                        <td align="center" rowspan="1" colspan="1">109(44.1%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Ever Pregnant (self-report)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">5(8.0%)</td>
                        <td align="center" rowspan="1" colspan="1">21(31.0%)</td>
                        <td align="center" rowspan="1" colspan="1">32(53.0%)</td>
                        <td align="center" rowspan="1" colspan="1">41(68.0%)</td>
                        <td align="center" rowspan="1" colspan="1">99(40.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Caregiver for</bold>
                          <underline>
                            <bold>&gt;</bold>
                          </underline>
                          <bold>1 child</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                        <td align="center" rowspan="1" colspan="1">22(33.0%)</td>
                        <td align="center" rowspan="1" colspan="1">21(35.0%)</td>
                        <td align="center" rowspan="1" colspan="1">34(57.0%)</td>
                        <td align="center" rowspan="1" colspan="1">86(35.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Diagnosed with STI</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">28(47.0%)</td>
                        <td align="center" rowspan="1" colspan="1">25(37.0%)</td>
                        <td align="center" rowspan="1" colspan="1">19(32.0%)</td>
                        <td align="center" rowspan="1" colspan="1">15(25.0%)</td>
                        <td align="center" rowspan="1" colspan="1">87(35.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="6" rowspan="1">
                          <bold>Worry about HIV infection in the Next Year</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Very Worried</td>
                        <td align="center" rowspan="1" colspan="1">22(37.0%)</td>
                        <td align="center" rowspan="1" colspan="1">19(28.0%)</td>
                        <td align="center" rowspan="1" colspan="1">6(10.0%)</td>
                        <td align="center" rowspan="1" colspan="1">24(40.0%)</td>
                        <td align="center" rowspan="1" colspan="1">71(29.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Somewhat worried</td>
                        <td align="center" rowspan="1" colspan="1">7(12.0%)</td>
                        <td align="center" rowspan="1" colspan="1">8(12.0%)</td>
                        <td align="center" rowspan="1" colspan="1">0(0.0%)</td>
                        <td align="center" rowspan="1" colspan="1">14(23.0%)</td>
                        <td align="center" rowspan="1" colspan="1">29(12.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> A little worried</td>
                        <td align="center" rowspan="1" colspan="1">23(38.0%)</td>
                        <td align="center" rowspan="1" colspan="1">23(34.0%)</td>
                        <td align="center" rowspan="1" colspan="1">10(17.0%)</td>
                        <td align="center" rowspan="1" colspan="1">12(20.0%)</td>
                        <td align="center" rowspan="1" colspan="1">68(28.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Not at all worried</td>
                        <td align="center" rowspan="1" colspan="1">8(13.0%)</td>
                        <td align="center" rowspan="1" colspan="1">17(25.0%)</td>
                        <td align="center" rowspan="1" colspan="1">44(73.0%)</td>
                        <td align="center" rowspan="1" colspan="1">10(17.0%)</td>
                        <td align="center" rowspan="1" colspan="1">79(32.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><bold>CES-D-10 Depression Scale</bold> (Median, IQR)</td>
                        <td align="center" rowspan="1" colspan="1">7.0 (5,10)</td>
                        <td align="center" rowspan="1" colspan="1">8.5 (4,13)</td>
                        <td align="center" rowspan="1" colspan="1">9.5 (6,15)</td>
                        <td align="center" rowspan="1" colspan="1">6.0 (5,11)</td>
                        <td align="center" rowspan="1" colspan="1">7.0 (5,12)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Depressive symptoms (CESD&gt; = 12)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                        <td align="center" rowspan="1" colspan="1">22<xref rid="t001fn002" ref-type="table-fn"><sup>b</sup></xref> (33.0%)</td>
                        <td align="center" rowspan="1" colspan="1">24(40.0%)</td>
                        <td align="center" rowspan="1" colspan="1">11<xref rid="t001fn003" ref-type="table-fn"><sup>c</sup></xref>
<sup>(</sup>23.0%)</td>
                        <td align="center" rowspan="1" colspan="1">66 <xref rid="t001fn004" ref-type="table-fn"><sup>d</sup></xref> (28.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Positive (AUDIT-C ≥ 3) indicative of hazardous drinking/alcohol abuse disorder</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">38(63.0%)</td>
                        <td align="center" rowspan="1" colspan="1">31(46.0%)</td>
                        <td align="center" rowspan="1" colspan="1">13(22.0%)</td>
                        <td align="center" rowspan="1" colspan="1">15<xref rid="t001fn005" ref-type="table-fn"><sup>e</sup></xref> (25.0%)</td>
                        <td align="center" rowspan="1" colspan="1">97<xref rid="t001fn006" ref-type="table-fn"><sup>f</sup></xref> (39.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><bold>New Brief Self-Control Scale</bold> (median, IQR)</td>
                        <td align="center" rowspan="1" colspan="1">27 (24,30)</td>
                        <td align="center" rowspan="1" colspan="1">27 (25,31)</td>
                        <td align="center" rowspan="1" colspan="1">24.5 (22,29)</td>
                        <td align="center" rowspan="1" colspan="1">28 (23,29)</td>
                        <td align="center" rowspan="1" colspan="1">27 (23,30)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><bold>Peer Social Support (MSPSS)</bold> (Median, IQR)</td>
                        <td align="center" rowspan="1" colspan="1">15 (12,16)</td>
                        <td align="center" rowspan="1" colspan="1">16 (12,16)</td>
                        <td align="center" rowspan="1" colspan="1">14 (12,16)</td>
                        <td align="center" rowspan="1" colspan="1">14.5 (11,16)</td>
                        <td align="center" rowspan="1" colspan="1">15 (12,16)</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t001fn001">
                    <p><sup>a</sup> Combination of the “copper IUD” (n = 26) and “hormonal IUD” (n = 1)</p>
                  </fn>
                  <fn id="t001fn002">
                    <p><sup>b</sup> Denominator = 66</p>
                  </fn>
                  <fn id="t001fn003">
                    <p><sup>c</sup> Denominator = 47</p>
                  </fn>
                  <fn id="t001fn004">
                    <p><sup>d</sup> Denominator = 233</p>
                  </fn>
                  <fn id="t001fn005">
                    <p><sup>e</sup>Denominator = 59</p>
                  </fn>
                  <fn id="t001fn006">
                    <p><sup>f</sup>Denominator = 246</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>The median age of sexual debut was 16 (IQR 12,19) which was one year younger than the median age of first contraception use, 17 (IQR 13, 21). By self-report, 40% of participants had previously been pregnant, ranging from 8% in Cape Town to 68% in Harare. By contrast, STI diagnosis at baseline was most prevalent among Cape Town based participants (47%) compared to the other sites (25%-37%).</p>
              <p>Overall, 28% of participants, and 40% of participants from Kampala, had CESD-10 scores suggestive of depressive symptoms (≥12) in the past week. Nearly 40% of participants overall, and 63% of participants from Cape Town had a positive score on the AUDIT-C, suggesting a high prevalence of alcohol use disorders in the study cohort. In contrast, moderate levels of self-control (median score of 27 out of 35) and peer social support (median score of 15 out of 20) were reported across sites.</p>
              <sec id="sec014">
                <title>Behavioral characteristics</title>
                <p>As shown in <xref rid="pone.0287525.t002" ref-type="table">Table 2</xref>, 89.1% of participants reported having a primary sexual partner. Median age of primary partners was 23 years (IQR 20,25). Approximately 60% of participants had been in their relationship for more than one year and received financial support from their primary partners. The majority of participants reported that their primary partners were HIV-negative (73.6%), while 25% did not know his status and only three women had a partner who they reported was living with HIV. A minority reported that their primary partners were definitely (7.7%) or possibly (15.5%) having sex with other partners. Many participants had experienced verbal (30%) or physical (15%) abuse or forced sex (11%) by an intimate partner, with reports varying substantially by site.</p>
                <table-wrap position="float" id="pone.0287525.t002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0287525.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Partner/partnership characteristics.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0287525.t002" id="pone.0287525.t002g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Characteristic</th>
                          <th align="center" rowspan="1" colspan="1">SA ‐ Cape Town</th>
                          <th align="center" rowspan="1" colspan="1">SA–Johannesburg</th>
                          <th align="left" rowspan="1" colspan="1">Uganda–Kampala</th>
                          <th align="center" rowspan="1" colspan="1">Zimbabwe–Harare</th>
                          <th align="center" rowspan="1" colspan="1">All Sites</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Participants Enrolled</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">60</td>
                          <td align="center" rowspan="1" colspan="1">67</td>
                          <td align="center" rowspan="1" colspan="1">60</td>
                          <td align="center" rowspan="1" colspan="1">60</td>
                          <td align="center" rowspan="1" colspan="1">247</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Currently has a primary sexual partner</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">53(88.3%)</td>
                          <td align="center" rowspan="1" colspan="1">61(91.0%)</td>
                          <td align="center" rowspan="1" colspan="1">54(90.0%)</td>
                          <td align="center" rowspan="1" colspan="1">52(86.7%)</td>
                          <td align="center" rowspan="1" colspan="1">220(89.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Median age of primary sexual partner (IQR)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">21 (19,23)</td>
                          <td align="center" rowspan="1" colspan="1">22 (22,24)</td>
                          <td align="center" rowspan="1" colspan="1">23 (20,26)</td>
                          <td align="center" rowspan="1" colspan="1">24 (22,26)</td>
                          <td align="center" rowspan="1" colspan="1">23 (20,25)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="6" rowspan="1">
                            <bold>Duration of partnership with primary partner</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Less than 3 months</td>
                          <td align="center" rowspan="1" colspan="1">5(9.4%)</td>
                          <td align="center" rowspan="1" colspan="1">3(4.9%)</td>
                          <td align="center" rowspan="1" colspan="1">4(7.4%)</td>
                          <td align="center" rowspan="1" colspan="1">5(9.6%)</td>
                          <td align="center" rowspan="1" colspan="1">17(7.7%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 3–12 months</td>
                          <td align="center" rowspan="1" colspan="1">22(41.5%)</td>
                          <td align="center" rowspan="1" colspan="1">14(23.0%)</td>
                          <td align="center" rowspan="1" colspan="1">18(33.3%)</td>
                          <td align="center" rowspan="1" colspan="1">14(26.9%)</td>
                          <td align="center" rowspan="1" colspan="1">68(30.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> More than 12 months</td>
                          <td align="center" rowspan="1" colspan="1">26(49.1%)</td>
                          <td align="center" rowspan="1" colspan="1">44(72.1%)</td>
                          <td align="center" rowspan="1" colspan="1">32(59.3%)</td>
                          <td align="center" rowspan="1" colspan="1">32(61.5%)</td>
                          <td align="center" rowspan="1" colspan="1">134(60.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Skipped by participant</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.9%)</td>
                          <td align="center" rowspan="1" colspan="1">1(0.5%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Primary sex partner provides financial and/or material support</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">18(34.0%)</td>
                          <td align="center" rowspan="1" colspan="1">32(52.5%)</td>
                          <td align="center" rowspan="1" colspan="1">44(81.5%)</td>
                          <td align="center" rowspan="1" colspan="1">42(80.8%)</td>
                          <td align="center" rowspan="1" colspan="1">136(61.8%)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="6" rowspan="1">
                            <bold>HIV status of primary sex partner</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV positive</td>
                          <td align="center" rowspan="1" colspan="1">1(1.9%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.6%)</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">1(1.9%)</td>
                          <td align="center" rowspan="1" colspan="1">3(1.4%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV negative</td>
                          <td align="center" rowspan="1" colspan="1">34(64.2%)</td>
                          <td align="center" rowspan="1" colspan="1">47(77.0%)</td>
                          <td align="center" rowspan="1" colspan="1">43(79.6%)</td>
                          <td align="center" rowspan="1" colspan="1">38(73.1%)</td>
                          <td align="center" rowspan="1" colspan="1">162(73.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Don’t know</td>
                          <td align="center" rowspan="1" colspan="1">18(34.0%)</td>
                          <td align="center" rowspan="1" colspan="1">13(21.3%)</td>
                          <td align="center" rowspan="1" colspan="1">11(20.4%)</td>
                          <td align="center" rowspan="1" colspan="1">13(25.0%)</td>
                          <td align="center" rowspan="1" colspan="1">55(25.0%)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="6" rowspan="1">
                            <bold>Primary sex partner had sex with another partner besides the study participant in the last 3 months</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Knows so</td>
                          <td align="center" rowspan="1" colspan="1">4(7.5%)</td>
                          <td align="center" rowspan="1" colspan="1">4(6.6%)</td>
                          <td align="center" rowspan="1" colspan="1">6(11.1%)</td>
                          <td align="center" rowspan="1" colspan="1">3(5.8%)</td>
                          <td align="center" rowspan="1" colspan="1">17(7.7%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Thinks so</td>
                          <td align="center" rowspan="1" colspan="1">6(11.3%)</td>
                          <td align="center" rowspan="1" colspan="1">10(16.4%)</td>
                          <td align="center" rowspan="1" colspan="1">8(14.8%)</td>
                          <td align="center" rowspan="1" colspan="1">10(19.2%)</td>
                          <td align="center" rowspan="1" colspan="1">34(15.5%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Physical abuse from intimate partner, last 6 months</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">3(5.0%)</td>
                          <td align="center" rowspan="1" colspan="1">3(4.5%)</td>
                          <td align="center" rowspan="1" colspan="1">11(18.3%)</td>
                          <td align="center" rowspan="1" colspan="1">19(31.7%)</td>
                          <td align="center" rowspan="1" colspan="1">36(14.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Verbal abuse from intimate partner, last 6 months</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">8(13.3%)</td>
                          <td align="center" rowspan="1" colspan="1">19(28.4%)</td>
                          <td align="center" rowspan="1" colspan="1">20(33.3%)</td>
                          <td align="center" rowspan="1" colspan="1">28(46.7%)</td>
                          <td align="center" rowspan="1" colspan="1">75(30.4%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Forced sex from intimate partner, last 6 months</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">4(6.0%)</td>
                          <td align="center" rowspan="1" colspan="1">14(23.3%)</td>
                          <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                          <td align="center" rowspan="1" colspan="1">27(10.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Forced Sex from non-intimate partner, last 6 months.</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">1(1.7%)</td>
                          <td align="center" rowspan="1" colspan="1">5(7.5%)</td>
                          <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                          <td align="center" rowspan="1" colspan="1">2(3.3%)</td>
                          <td align="center" rowspan="1" colspan="1">17(6.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Vaginal sex, past 3 months</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">50 (83.3%)</td>
                          <td align="center" rowspan="1" colspan="1">64(95.5%)</td>
                          <td align="center" rowspan="1" colspan="1">49(81.7%)</td>
                          <td align="center" rowspan="1" colspan="1">40(69.0%)</td>
                          <td align="center" rowspan="1" colspan="1">203<xref rid="t002fn001" ref-type="table-fn">*</xref>(82.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="6" rowspan="1">
                            <bold>Vaginal Sex in the past 30 days</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> N</td>
                          <td align="center" rowspan="1" colspan="1">50</td>
                          <td align="center" rowspan="1" colspan="1">64</td>
                          <td align="center" rowspan="1" colspan="1">49</td>
                          <td align="center" rowspan="1" colspan="1">40</td>
                          <td align="center" rowspan="1" colspan="1">203</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Median (IQR)</td>
                          <td align="center" rowspan="1" colspan="1">4(2,5)</td>
                          <td align="center" rowspan="1" colspan="1">3.5 (2,7)</td>
                          <td align="center" rowspan="1" colspan="1">5 (2,8)</td>
                          <td align="center" rowspan="1" colspan="1">4 (1,11)</td>
                          <td align="center" rowspan="1" colspan="1">4 (2,7)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Condom used last vaginal sexual act</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">31(62.0%)</td>
                          <td align="center" rowspan="1" colspan="1">37(57.8%)</td>
                          <td align="center" rowspan="1" colspan="1">24(49.0%)</td>
                          <td align="center" rowspan="1" colspan="1">21(50.0%)</td>
                          <td align="center" rowspan="1" colspan="1">113(55.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Anal sex in the last 3 months</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">6(10.0%)</td>
                          <td align="center" rowspan="1" colspan="1">4(6.0%)</td>
                          <td align="center" rowspan="1" colspan="1">6 (10.0%)</td>
                          <td align="center" rowspan="1" colspan="1">3(5.0%)</td>
                          <td align="center" rowspan="1" colspan="1">19(7.7%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Condom used last act of anal sex</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">5(83.3%)</td>
                          <td align="center" rowspan="1" colspan="1">3(75.0%)</td>
                          <td align="center" rowspan="1" colspan="1">5(83.3%)</td>
                          <td align="center" rowspan="1" colspan="1">3(100.0%)</td>
                          <td align="center" rowspan="1" colspan="1">16(84.2%)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="6" rowspan="1">
                            <bold>Number of male sexual partners in the past 3 months (categorical)</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 0</td>
                          <td align="center" rowspan="1" colspan="1">5(8.3%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">3(5.0%)</td>
                          <td align="center" rowspan="1" colspan="1">4(6.7%)</td>
                          <td align="center" rowspan="1" colspan="1">12(4.9%) <xref rid="t002fn001" ref-type="table-fn">*</xref></td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 1</td>
                          <td align="center" rowspan="1" colspan="1">36(60.0%)</td>
                          <td align="center" rowspan="1" colspan="1">44(65.7%)</td>
                          <td align="center" rowspan="1" colspan="1">27(45.0%)</td>
                          <td align="center" rowspan="1" colspan="1">39(65.0%)</td>
                          <td align="center" rowspan="1" colspan="1">146(59.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 2+</td>
                          <td align="center" rowspan="1" colspan="1">19(31.7%)</td>
                          <td align="center" rowspan="1" colspan="1">23(34.3%)</td>
                          <td align="center" rowspan="1" colspan="1">30(50.0%)</td>
                          <td align="center" rowspan="1" colspan="1">17(28.3%)</td>
                          <td align="center" rowspan="1" colspan="1">89(36.0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Median number of sexual partners in the past 3 months (IQR)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">1(1,2)</td>
                          <td align="center" rowspan="1" colspan="1">1(1,2)</td>
                          <td align="center" rowspan="1" colspan="1">1(1,3)</td>
                          <td align="center" rowspan="1" colspan="1">1(1,2)</td>
                          <td align="center" rowspan="1" colspan="1">1(1,2)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Transactional sex in the past 6 months</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">7(11.7%)</td>
                          <td align="center" rowspan="1" colspan="1">10(14.9%)</td>
                          <td align="center" rowspan="1" colspan="1">33(55.0%)</td>
                          <td align="center" rowspan="1" colspan="1">16(26.7%)</td>
                          <td align="center" rowspan="1" colspan="1">66(26.7%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>*The numbers are mismatched due to inconsistency in participants’ self-report (If 12 participants had 0 partners, then the total number of participants who had vaginal sex in the last 3 months should be 235)</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Overall, 82.2% of participants reported having had sex at least once in the three months preceding screening. Among these participants, vaginal sex occurred four times per month on average (IQR 2,7). Condom use at last sex was reported by a little more than half of participants, with minimal variation by site. Although only 19 participants reported having anal sex in the 3 months prior to screening, 84% of those participants reported having used a condom during the last anal sex act. The majority of participants reported having had only one partner in the three months before screening, whereas 36% reported multiple partners. More than one-quarter of the participants reported engaging in transactional sex, which varied by site from 12% in Cape Town to 55% in Kampala.</p>
                <p>Most participants had disclosed their intention to use oral PrEP or the ring during the study to female family members (87.0%), friends (79.4%), and primary partners (60.3%), whereas only 23.9% of participants told male family members about intention to use the products (<xref rid="pone.0287525.t003" ref-type="table">Table 3</xref>). When asked prior to initiation, how much they thought they would like to use each of the products for HIV prevention, 74.1% said they would like or like very much using the ring and 77.7% said they would like or like very much using oral PrEP. Baseline preference was similar for using the ring (38.1%) or oral PrEP (40.5%), with 19% of participants stating they preferred both products equally and only four (1.6%) stated they liked neither.</p>
                <table-wrap position="float" id="pone.0287525.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0287525.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Disclosure and preference for HIV prevention.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0287525.t003" id="pone.0287525.t003g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Characteristic</th>
                          <th align="center" rowspan="1" colspan="1">SA ‐ Cape Town</th>
                          <th align="center" rowspan="1" colspan="1">SA–Johannesburg</th>
                          <th align="center" rowspan="1" colspan="1">Uganda–Kampala</th>
                          <th align="center" rowspan="1" colspan="1">Zimbabwe–Harare</th>
                          <th align="center" rowspan="1" colspan="1">All Sites</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Participants with Enrollment ACASI</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">60</td>
                          <td align="center" rowspan="1" colspan="1">67</td>
                          <td align="center" rowspan="1" colspan="1">60</td>
                          <td align="center" rowspan="1" colspan="1">60</td>
                          <td align="center" rowspan="1" colspan="1">247</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Disclosed to primary sex partner about intention to use oral PrEP or Ring</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">36(60.0%)</td>
                          <td align="center" rowspan="1" colspan="1">47(70.1%)</td>
                          <td align="center" rowspan="1" colspan="1">31(51.7%)</td>
                          <td align="center" rowspan="1" colspan="1">35(58.3%)</td>
                          <td align="center" rowspan="1" colspan="1">149(60.3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Disclosed to any female family member(s) about intention to use oral PrEP or Ring</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">55(91.7%)</td>
                          <td align="center" rowspan="1" colspan="1">59(88.1%)</td>
                          <td align="center" rowspan="1" colspan="1">46(76.7%)</td>
                          <td align="center" rowspan="1" colspan="1">55(91.7%)</td>
                          <td align="center" rowspan="1" colspan="1">215(87.0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Disclosed to any male family member(s) about intention to use oral PrEP or Ring</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">18(30.0%)</td>
                          <td align="center" rowspan="1" colspan="1">20(29.9%)</td>
                          <td align="center" rowspan="1" colspan="1">9(15.0%)</td>
                          <td align="center" rowspan="1" colspan="1">12(20.0%)</td>
                          <td align="center" rowspan="1" colspan="1">59(23.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Disclosed to friend(s) about intention to use oral PrEP or Ring</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">56(93.3%)</td>
                          <td align="center" rowspan="1" colspan="1">54(80.6%)</td>
                          <td align="center" rowspan="1" colspan="1">46(76.7%)</td>
                          <td align="center" rowspan="1" colspan="1">40(66.7%)</td>
                          <td align="center" rowspan="1" colspan="1">196(79.4%)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="6" rowspan="1">
                            <bold>Prefers to use the Ring or oral PrEP for HIV prevention</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Ring</td>
                          <td align="center" rowspan="1" colspan="1">21(35.0%)</td>
                          <td align="center" rowspan="1" colspan="1">33(49.3%)</td>
                          <td align="center" rowspan="1" colspan="1">21(35.0%)</td>
                          <td align="center" rowspan="1" colspan="1">19(31.7%)</td>
                          <td align="center" rowspan="1" colspan="1">94(38.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Oral PrEP</td>
                          <td align="center" rowspan="1" colspan="1">27(45.0%)</td>
                          <td align="center" rowspan="1" colspan="1">24(35.8%)</td>
                          <td align="center" rowspan="1" colspan="1">16(26.7%)</td>
                          <td align="center" rowspan="1" colspan="1">33(55.0%)</td>
                          <td align="center" rowspan="1" colspan="1">100(40.5%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Either product equally</td>
                          <td align="center" rowspan="1" colspan="1">11(18.3%)</td>
                          <td align="center" rowspan="1" colspan="1">8(11.9%)</td>
                          <td align="center" rowspan="1" colspan="1">23(38.3%)</td>
                          <td align="center" rowspan="1" colspan="1">5(8.3%)</td>
                          <td align="center" rowspan="1" colspan="1">47(19.0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Neither product</td>
                          <td align="center" rowspan="1" colspan="1">1(1.7%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.5%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">2(3.3%)</td>
                          <td align="center" rowspan="1" colspan="1">4(1.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Skipped by participant</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.5%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.7%)</td>
                          <td align="center" rowspan="1" colspan="1">2(0.8%)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="6" rowspan="1">
                            <bold>Pre-use opinion of using the Ring for HIV prevention</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Dislike very much</td>
                          <td align="center" rowspan="1" colspan="1">4(6.7%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">3(5.0%)</td>
                          <td align="center" rowspan="1" colspan="1">12(20.0%)</td>
                          <td align="center" rowspan="1" colspan="1">19(7.7%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Dislike</td>
                          <td align="center" rowspan="1" colspan="1">1(1.7%)</td>
                          <td align="center" rowspan="1" colspan="1">5(7.5%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">6(10.0%)</td>
                          <td align="center" rowspan="1" colspan="1">12(4.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Neither like nor dislike</td>
                          <td align="center" rowspan="1" colspan="1">11(18.3%)</td>
                          <td align="center" rowspan="1" colspan="1">12(17.9%)</td>
                          <td align="center" rowspan="1" colspan="1">4(6.7%)</td>
                          <td align="center" rowspan="1" colspan="1">3(5.0%)</td>
                          <td align="center" rowspan="1" colspan="1">30(12.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Like</td>
                          <td align="center" rowspan="1" colspan="1">27(45.0%)</td>
                          <td align="center" rowspan="1" colspan="1">25(37.3%)</td>
                          <td align="center" rowspan="1" colspan="1">21(35.0%)</td>
                          <td align="center" rowspan="1" colspan="1">30(50.0%)</td>
                          <td align="center" rowspan="1" colspan="1">103(41.7%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Like very much</td>
                          <td align="center" rowspan="1" colspan="1">17(28.3%)</td>
                          <td align="center" rowspan="1" colspan="1">24(35.8%)</td>
                          <td align="center" rowspan="1" colspan="1">32(53.3%)</td>
                          <td align="center" rowspan="1" colspan="1">7(11.7%)</td>
                          <td align="center" rowspan="1" colspan="1">80(32.4%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Skipped by participant</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.5%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">2(3.3%)</td>
                          <td align="center" rowspan="1" colspan="1">3(1.2%)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="6" rowspan="1">
                            <bold>Pre-use opinion of using oral PrEP for HIV prevention</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Dislike very much</td>
                          <td align="center" rowspan="1" colspan="1">3(5.0%)</td>
                          <td align="center" rowspan="1" colspan="1">2(3.0%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.7%)</td>
                          <td align="center" rowspan="1" colspan="1">2(3.3%)</td>
                          <td align="center" rowspan="1" colspan="1">8(3.2%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Dislike</td>
                          <td align="center" rowspan="1" colspan="1">4(6.7%)</td>
                          <td align="center" rowspan="1" colspan="1">4(6.0%)</td>
                          <td align="center" rowspan="1" colspan="1">2(3.3%)</td>
                          <td align="center" rowspan="1" colspan="1">2(3.3%)</td>
                          <td align="center" rowspan="1" colspan="1">12(4.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Neither like nor dislike</td>
                          <td align="center" rowspan="1" colspan="1">11(18.3%)</td>
                          <td align="center" rowspan="1" colspan="1">15(22.4%)</td>
                          <td align="center" rowspan="1" colspan="1">5(8.3%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.7%)</td>
                          <td align="center" rowspan="1" colspan="1">32(13.0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Like</td>
                          <td align="center" rowspan="1" colspan="1">19(31.7%)</td>
                          <td align="center" rowspan="1" colspan="1">32(47.8%)</td>
                          <td align="center" rowspan="1" colspan="1">23(38.3%)</td>
                          <td align="center" rowspan="1" colspan="1">35(58.3%)</td>
                          <td align="center" rowspan="1" colspan="1">109(44.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Like very much</td>
                          <td align="center" rowspan="1" colspan="1">23(38.3%)</td>
                          <td align="center" rowspan="1" colspan="1">13(19.4%)</td>
                          <td align="center" rowspan="1" colspan="1">29(48.3%)</td>
                          <td align="center" rowspan="1" colspan="1">18(30.0%)</td>
                          <td align="center" rowspan="1" colspan="1">83(33.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Skipped by participant</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">1(1.5%)</td>
                          <td align="center" rowspan="1" colspan="1">0(0%)</td>
                          <td align="center" rowspan="1" colspan="1">2(3.3%)</td>
                          <td align="center" rowspan="1" colspan="1">3(1.2%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec015">
                <title>Characteristics associated with preference for oral PrEP or the ring</title>
                <p>We modeled the associations between baseline demographic and behavioral characteristics and preference for oral PrEP, the ring, or both products equally, controlling for site and age (<xref rid="pone.0287525.t004" ref-type="table">Table 4</xref>). Furthermore, associations for site (controlling for age) and age (controlling for site) were also modeled. None of the characteristics were significant, except site (P&lt;0.001, adjusted for age). Compared to participants from Zimbabwe, participants from Johannesburg had twice the odds of preferring the ring versus oral PrEP (OR 2.20; 95% CI 1.01–4.80) and participants from Uganda had nine times the odds of being interested in both methods equally versus oral PrEP (OR 9.14; 95% CI: 2.92–28.60). Although not statistically significant after adjusting for multiple comparisons, those who reported being at least a little worried about HIV acquisition had lower odds of preferring the ring (OR 0.47; 95% CI 0.23–0.99) and those who reported forced sex from non-intimate partner in the last 6 months also had lower odds of preferring the ring (OR 0.18; 95% CI 0.04–0.88). Those who reported condom use with last sex had twice to the odds of preferring the ring, and twice the odds of preferring both the ring and oral PrEP equally (OR 2.04; 95% CI 1.03–4.02) and (OR 2.36; 95% CI 1.03–5.44) respectively. Preference for ring or for both products was similarly higher with higher education level (OR 3.17; 95% CI 0.83–12.11) and (OR 4.24; 95% CI 0.97–18.51), respectively, although this was not statistically significant.</p>
                <table-wrap position="float" id="pone.0287525.t004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0287525.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Preference for oral PrEP or ring by baseline characteristics: Results from multinomial logistic regression with “Prefer PrEP” as reference level.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0287525.t004" id="pone.0287525.t004g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Characteristic</th>
                          <th align="center" rowspan="1" colspan="1">Prefer PrEP n (%)/mean (IQR)</th>
                          <th align="center" rowspan="1" colspan="1">Prefer Ring n (%)/mean (IQR)</th>
                          <th align="center" rowspan="1" colspan="1">Both equally n (%)/mean (IQR)</th>
                          <th align="center" rowspan="1" colspan="1">Prefer Ring Adjusted Odds Ratio (95% CI)</th>
                          <th align="center" rowspan="1" colspan="1">Both Equally Adjusted Odds Ratio (95% CI)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Marital status</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Single</td>
                          <td align="center" rowspan="1" colspan="1">87 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">81 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">42 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Married/ cohabitating</td>
                          <td align="center" rowspan="1" colspan="1">12 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">12 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">4 (14%)</td>
                          <td align="center" rowspan="1" colspan="1">1.44 (0.53–3.93)</td>
                          <td align="center" rowspan="1" colspan="1">1.03 (0.25–4.22)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Separated/divorced</td>
                          <td align="center" rowspan="1" colspan="1">1 (33%)</td>
                          <td align="center" rowspan="1" colspan="1">1 (33%)</td>
                          <td align="center" rowspan="1" colspan="1">1 (33%)</td>
                          <td align="center" rowspan="1" colspan="1">1.93 (0.11–34.00)</td>
                          <td align="center" rowspan="1" colspan="1">7.76 (0.38–156.86)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age</bold>
                            <xref rid="t004fn002" ref-type="table-fn">
                              <sup>
                                <bold>2</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 16–17</td>
                          <td align="center" rowspan="1" colspan="1">41 (49%)</td>
                          <td align="center" rowspan="1" colspan="1">27 (33%)</td>
                          <td align="center" rowspan="1" colspan="1">15 (18%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 18–21</td>
                          <td align="center" rowspan="1" colspan="1">59 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">67 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">32 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">1.60 (0.87–2.95)</td>
                          <td align="center" rowspan="1" colspan="1">1.36 (0.63–2.95)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Highest level of school attended</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Secondary</td>
                          <td align="center" rowspan="1" colspan="1">84 (46%)</td>
                          <td align="center" rowspan="1" colspan="1">71 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">29 (16%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Tertiary</td>
                          <td align="center" rowspan="1" colspan="1">3 (13%)</td>
                          <td align="center" rowspan="1" colspan="1">12 (52%)</td>
                          <td align="center" rowspan="1" colspan="1">8 (35%)</td>
                          <td align="center" rowspan="1" colspan="1">3.17 (0.83–12.11)</td>
                          <td align="center" rowspan="1" colspan="1">4.24 (0.97–18.51)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Primary</td>
                          <td align="center" rowspan="1" colspan="1">13 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">9 (28%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (31%)</td>
                          <td align="center" rowspan="1" colspan="1">0.56 (0.17–1.87)</td>
                          <td align="center" rowspan="1" colspan="1">0.60 (0.17–2.14)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Earns own income</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">82 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">71 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">37 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">18 (35%)</td>
                          <td align="center" rowspan="1" colspan="1">23 (45%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">1.44 (0.63–3.25)</td>
                          <td align="center" rowspan="1" colspan="1">0.52 (0.18–1.48)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Pregnancy history</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Never pregnant</td>
                          <td align="center" rowspan="1" colspan="1">63 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">54 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">29 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Ever pregnant</td>
                          <td align="center" rowspan="1" colspan="1">37 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">40 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">18 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">1.33 (0.66–2.69)</td>
                          <td align="center" rowspan="1" colspan="1">0.96 (0.40–2.33)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Worry about HIV infection</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Not at all worried</td>
                          <td align="center" rowspan="1" colspan="1">24 (31%)</td>
                          <td align="center" rowspan="1" colspan="1">37 (47%)</td>
                          <td align="center" rowspan="1" colspan="1">17 (22%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> At least a little worried</td>
                          <td align="center" rowspan="1" colspan="1">76 (47%)</td>
                          <td align="center" rowspan="1" colspan="1">57 (35%)</td>
                          <td align="center" rowspan="1" colspan="1">30 (18%)</td>
                          <td align="center" rowspan="1" colspan="1">0.47 (0.23–0.99)</td>
                          <td align="center" rowspan="1" colspan="1">1.51 (0.56–4.04)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age of sexual debut</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1">15.9 (15.0–17.0)</td>
                          <td align="center" rowspan="1" colspan="1">16.0 (15.0–17.0)</td>
                          <td align="center" rowspan="1" colspan="1">15.6 (15.0–16.0)</td>
                          <td align="center" rowspan="1" colspan="1">0.94 (0.72–1.23)</td>
                          <td align="center" rowspan="1" colspan="1">0.79 (0.57–1.09)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Baseline contraceptive method</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Implants</td>
                          <td align="center" rowspan="1" colspan="1">45 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">46 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">17 (16%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> IUD</td>
                          <td align="center" rowspan="1" colspan="1">10 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">7 (26%)</td>
                          <td align="center" rowspan="1" colspan="1">1.08 (0.40–2.95)</td>
                          <td align="center" rowspan="1" colspan="1">2.25 (0.67–7.57)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Injectable contraceptive</td>
                          <td align="center" rowspan="1" colspan="1">45 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">38 (36%)</td>
                          <td align="center" rowspan="1" colspan="1">23 (22%)</td>
                          <td align="center" rowspan="1" colspan="1">0.84 (0.43–1.64)</td>
                          <td align="center" rowspan="1" colspan="1">1.97 (0.81–4.82)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>AUDIT-C (categorical)</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Negative (&lt; 3)</td>
                          <td align="center" rowspan="1" colspan="1">62 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">56 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">27 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Positive (≥3)</td>
                          <td align="center" rowspan="1" colspan="1">38 (40%)</td>
                          <td align="center" rowspan="1" colspan="1">38 (40%)</td>
                          <td align="center" rowspan="1" colspan="1">20 (21%)</td>
                          <td align="center" rowspan="1" colspan="1">1.12 (0.60–2.09)</td>
                          <td align="center" rowspan="1" colspan="1">1.60 (0.72–3.57)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Participant has a regular place to store own things</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">85 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">78 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">37 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">15 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">16 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (24%)</td>
                          <td align="center" rowspan="1" colspan="1">1.40 (0.63–3.10)</td>
                          <td align="center" rowspan="1" colspan="1">1.87 (0.72–4.86)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Current living situation</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Lives with parents</td>
                          <td align="center" rowspan="1" colspan="1">68 (45%)</td>
                          <td align="center" rowspan="1" colspan="1">53 (35%)</td>
                          <td align="center" rowspan="1" colspan="1">30 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Lives alone</td>
                          <td align="center" rowspan="1" colspan="1">2 (22%)</td>
                          <td align="center" rowspan="1" colspan="1">5 (56%)</td>
                          <td align="center" rowspan="1" colspan="1">2 (22%)</td>
                          <td align="center" rowspan="1" colspan="1">2.97 (0.52–17.05)</td>
                          <td align="center" rowspan="1" colspan="1">1.15 (0.13–9.75)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Lives with non-family members</td>
                          <td align="center" rowspan="1" colspan="1">6 (32%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (53%)</td>
                          <td align="center" rowspan="1" colspan="1">3 (16%)</td>
                          <td align="center" rowspan="1" colspan="1">2.10 (0.69–6.35)</td>
                          <td align="center" rowspan="1" colspan="1">1.14 (0.25–5.23)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Lives with non-parent family members</td>
                          <td align="center" rowspan="1" colspan="1">15 (38%)</td>
                          <td align="center" rowspan="1" colspan="1">17 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">8 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">1.37 (0.61–3.11)</td>
                          <td align="center" rowspan="1" colspan="1">0.85 (0.30–2.42)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Currently has primary sex partner</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">13 (48%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">4 (15%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">87 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">84 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">43 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">1.15 (0.47–2.83)</td>
                          <td align="center" rowspan="1" colspan="1">1.49 (0.44–5.13)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Difference in age between participant and partner</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1">5.0 (2.0–7.0)</td>
                          <td align="center" rowspan="1" colspan="1">4.6 (2.0–7.0)</td>
                          <td align="center" rowspan="1" colspan="1">4.6 (3.0–6.0)</td>
                          <td align="center" rowspan="1" colspan="1">0.97 (0.88–1.06)</td>
                          <td align="center" rowspan="1" colspan="1">0.96 (0.85–1.08)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Duration of partnership with primary partner</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Less than 12 months</td>
                          <td align="center" rowspan="1" colspan="1">33 (40%)</td>
                          <td align="center" rowspan="1" colspan="1">31 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">19 (23%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> More than 12 months</td>
                          <td align="center" rowspan="1" colspan="1">54 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">52 (40%)</td>
                          <td align="center" rowspan="1" colspan="1">24 (18%)</td>
                          <td align="center" rowspan="1" colspan="1">0.90 (0.47–1.73)</td>
                          <td align="center" rowspan="1" colspan="1">0.77 (0.35–1.71)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Partner provides financial support</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">30 (36%)</td>
                          <td align="center" rowspan="1" colspan="1">35 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">18 (22%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">57 (44%)</td>
                          <td align="center" rowspan="1" colspan="1">49 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">25 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">0.70 (0.35–1.40)</td>
                          <td align="center" rowspan="1" colspan="1">0.50 (0.20–1.21)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>HIV status of primary partner</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV negative</td>
                          <td align="center" rowspan="1" colspan="1">60 (38%)</td>
                          <td align="center" rowspan="1" colspan="1">66 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">30 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV positive or don’t know</td>
                          <td align="center" rowspan="1" colspan="1">27 (47%)</td>
                          <td align="center" rowspan="1" colspan="1">18 (31%)</td>
                          <td align="center" rowspan="1" colspan="1">13 (22%)</td>
                          <td align="center" rowspan="1" colspan="1">0.66 (0.33–1.35)</td>
                          <td align="center" rowspan="1" colspan="1">1.15 (0.49–2.70)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Physical abuse from intimate partner in last 6 months</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">86 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">81 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">39 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">14 (40%)</td>
                          <td align="center" rowspan="1" colspan="1">13 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">8 (23%)</td>
                          <td align="center" rowspan="1" colspan="1">1.25 (0.52–3.01)</td>
                          <td align="center" rowspan="1" colspan="1">1.53 (0.53–4.48)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Verbal abuse from intimate partner in last 6 months</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">74 (44%)</td>
                          <td align="center" rowspan="1" colspan="1">63 (38%)</td>
                          <td align="center" rowspan="1" colspan="1">30 (18%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">26 (35%)</td>
                          <td align="center" rowspan="1" colspan="1">31 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">17 (23%)</td>
                          <td align="center" rowspan="1" colspan="1">1.53 (0.79–2.97)</td>
                          <td align="center" rowspan="1" colspan="1">1.96 (0.86–4.46)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Forced sex from intimate partner in last 6 months</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">88 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">84 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">42 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">12 (44%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">5 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">0.85 (0.33–2.22)</td>
                          <td align="center" rowspan="1" colspan="1">0.56 (0.16–1.92)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Forced sex from non-intimate partner in last 6 months</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">91 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">92 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">41 (18%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">9 (53%)</td>
                          <td align="center" rowspan="1" colspan="1">2 (12%)</td>
                          <td align="center" rowspan="1" colspan="1">6 (35%)</td>
                          <td align="center" rowspan="1" colspan="1">0.18 (0.04–0.88)</td>
                          <td align="center" rowspan="1" colspan="1">0.95 (0.28–3.23)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Vaginal sex in last 6 months</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">24 (59%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (24%)</td>
                          <td align="center" rowspan="1" colspan="1">7 (17%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">75 (38%)</td>
                          <td align="center" rowspan="1" colspan="1">84 (42%)</td>
                          <td align="center" rowspan="1" colspan="1">40 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">2.21 (0.96–5.10)</td>
                          <td align="center" rowspan="1" colspan="1">1.73 (0.63–4.71)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Condom use in last sex act</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">51 (46%)</td>
                          <td align="center" rowspan="1" colspan="1">42 (38%)</td>
                          <td align="center" rowspan="1" colspan="1">19 (17%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">24 (28%)</td>
                          <td align="center" rowspan="1" colspan="1">41 (48%)</td>
                          <td align="center" rowspan="1" colspan="1">21 (24%)</td>
                          <td align="center" rowspan="1" colspan="1">2.04 (1.03–4.02)</td>
                          <td align="center" rowspan="1" colspan="1">2.36 (1.03–5.44)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Anal sex, last 3 months</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">89 (40%)</td>
                          <td align="center" rowspan="1" colspan="1">88 (40%)</td>
                          <td align="center" rowspan="1" colspan="1">45 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">11 (58%)</td>
                          <td align="center" rowspan="1" colspan="1">6 (32%)</td>
                          <td align="center" rowspan="1" colspan="1">2 (11%)</td>
                          <td align="center" rowspan="1" colspan="1">0.55 (0.19–1.60)</td>
                          <td align="center" rowspan="1" colspan="1">0.28 (0.06–1.40)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Number of male sex partners in last 3 months</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> ≤ 1</td>
                          <td align="center" rowspan="1" colspan="1">67 (44%)</td>
                          <td align="center" rowspan="1" colspan="1">59 (39%)</td>
                          <td align="center" rowspan="1" colspan="1">27 (18%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 2+</td>
                          <td align="center" rowspan="1" colspan="1">33 (38%)</td>
                          <td align="center" rowspan="1" colspan="1">35 (40%)</td>
                          <td align="center" rowspan="1" colspan="1">20 (23%)</td>
                          <td align="center" rowspan="1" colspan="1">1.07 (0.58–1.96)</td>
                          <td align="center" rowspan="1" colspan="1">1.12 (0.52–2.40)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Transactional sex in last 6 months</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">71 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">72 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">32 (18%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">29 (44%)</td>
                          <td align="center" rowspan="1" colspan="1">22 (33%)</td>
                          <td align="center" rowspan="1" colspan="1">15 (23%)</td>
                          <td align="center" rowspan="1" colspan="1">0.63 (0.31–1.29)</td>
                          <td align="center" rowspan="1" colspan="1">0.61 (0.25–1.47)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Disclosure to primary sex partner about intention to use PrEP or Ring</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">42 (49%)</td>
                          <td align="center" rowspan="1" colspan="1">27 (31%)</td>
                          <td align="center" rowspan="1" colspan="1">17 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">53 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">62 (43%)</td>
                          <td align="center" rowspan="1" colspan="1">28 (20%)</td>
                          <td align="center" rowspan="1" colspan="1">1.78 (0.95–3.32)</td>
                          <td align="center" rowspan="1" colspan="1">1.48 (0.68–3.21)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>STI diagnosed at baseline</bold>
                            <xref rid="t004fn001" ref-type="table-fn">
                              <sup>
                                <bold>1</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> No</td>
                          <td align="center" rowspan="1" colspan="1">71 (46%)</td>
                          <td align="center" rowspan="1" colspan="1">59 (38%)</td>
                          <td align="center" rowspan="1" colspan="1">26 (17%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Yes</td>
                          <td align="center" rowspan="1" colspan="1">29 (34%)</td>
                          <td align="center" rowspan="1" colspan="1">35 (41%)</td>
                          <td align="center" rowspan="1" colspan="1">21 (25%)</td>
                          <td align="center" rowspan="1" colspan="1">1.40 (0.75–2.61)</td>
                          <td align="center" rowspan="1" colspan="1">2.04 (0.94–4.40)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Site</bold>
                            <xref rid="t004fn003" ref-type="table-fn">
                              <sup>
                                <bold>3</bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Zimbabwe ‐ Harare</td>
                          <td align="center" rowspan="1" colspan="1">33 (58%)</td>
                          <td align="center" rowspan="1" colspan="1">19 (33%)</td>
                          <td align="center" rowspan="1" colspan="1">5 (9%)</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                          <td align="center" rowspan="1" colspan="1">REF</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> SA ‐ Cape Town</td>
                          <td align="center" rowspan="1" colspan="1">27 (46%)</td>
                          <td align="center" rowspan="1" colspan="1">21 (36%)</td>
                          <td align="center" rowspan="1" colspan="1">11 (19%)</td>
                          <td align="center" rowspan="1" colspan="1">1.25 (0.56–2.82)</td>
                          <td align="center" rowspan="1" colspan="1">2.56 (0.79–8.32)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> SA ‐ Johannesburg</td>
                          <td align="center" rowspan="1" colspan="1">24 (37%)</td>
                          <td align="center" rowspan="1" colspan="1">33 (51%)</td>
                          <td align="center" rowspan="1" colspan="1">8 (12%)</td>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>2.20 (1.01–4.80)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">2.08 (0.60–7.21)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Uganda ‐ Kampala</td>
                          <td align="center" rowspan="1" colspan="1">16 (27%)</td>
                          <td align="center" rowspan="1" colspan="1">21 (35%)</td>
                          <td align="center" rowspan="1" colspan="1">23 (38%)</td>
                          <td align="center" rowspan="1" colspan="1">2.16 (0.91–5.14)</td>
                          <td align="center" rowspan="1" colspan="1"><bold>9.14 (2.92–28.60</bold>)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t004fn001">
                      <p><sup>1</sup> Adjusted for site and age</p>
                    </fn>
                    <fn id="t004fn002">
                      <p><sup>2</sup> Adjusted for site</p>
                    </fn>
                    <fn id="t004fn003">
                      <p><sup>3</sup> Adjusted for age</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec016">
              <title>Discussion</title>
              <p>The vanguard REACH crossover trial of the ring and oral PrEP implemented at four sites in three countries in Southern and East Africa demonstrates the feasibility of enrolling sexually active AGYW in Africa, with and without parental consent. Written informed assent and parental/guardian consent was obtained from all minors aged 16–17, and those who turned 18 during the study subsequently signed the ICF. The REACH cohort was diverse geographically with 34% of minors (16–17) and with an average age of 18 years old, an age group which experienced high HIV incidence in sub-Saharan Africa and poor adherence to oral PrEP and ring in previous studies [<xref rid="pone.0287525.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0287525.ref010" ref-type="bibr">10</xref>].</p>
              <p>Prevalence of STIs in this cohort was high with similarly high rates of STIs being reported in studies of AGYW in other SSA settings [<xref rid="pone.0287525.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0287525.ref028" ref-type="bibr">28</xref>]. These high rates of STIs are concerning especially because some STIs increase the possibility of HIV acquisition and the resultant long-term health consequences especially undiagnosed or untreated [<xref rid="pone.0287525.ref025" ref-type="bibr">25</xref>]. This high STI prevalence was further compounded by high reported intimate partner violence, including reports of forced sex (10.9%), an important contributor to HIV acquisition among AGYW [<xref rid="pone.0287525.ref029" ref-type="bibr">29</xref>].</p>
              <p>The median age of sexual debut was a year earlier, on average, than starting contraceptive. A gap in protection against unintended pregnancy- which may explain the 40% who reported to ever been pregnant at this young age. This unmet need for contraception coupled with the high HIV risk highlights once again the twin challenges faced by these young women in SSA. Therefore, multipurpose technology products currently in development could be ideal for this population.</p>
              <p>Multiple HIV prevention trials among AGYW have shown that adherence to oral PrEP and the ring can be challenging for AGYW [<xref rid="pone.0287525.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0287525.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0287525.ref030" ref-type="bibr">30</xref>–<xref rid="pone.0287525.ref033" ref-type="bibr">33</xref>]. Our study was designed to provide an opportunity for participants to experience both products during the randomized periods and provide an opportunity for AGYW to choose their preferred method during a third period. Preference for oral PrEP or the ring at baseline was not significantly different and the only factor predicting preference was study site. Given that pre-initiation product preference can inform initial choice among PrEP-naive AGYW, our findings suggest that multiple biomedical prevention options may be appealing to this age group and could address their prevention needs [<xref rid="pone.0287525.ref034" ref-type="bibr">34</xref>]. Our findings also add to the growing literature showing that interest and acceptability for different prevention methods vary by geography and cultural context, and thus, a menu of options would be most beneficial to increase protection coverage [<xref rid="pone.0287525.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0287525.ref038" ref-type="bibr">38</xref>]. Our results are similar to the monitoring pre-exposure prophylaxis for young adult women (MPYA) study, which also found no association between demographic or behavioral factors and preference for oral PrEP or the ring [<xref rid="pone.0287525.ref039" ref-type="bibr">39</xref>]. Notably in the MPYA study participants had used PrEP for up to 24 months. However, our findings contrast with the tablets, ring, injections as options (TRIO) study results in which women using long-acting reversible contraception (LARC) at baseline preferred a ring over injections or tablets. Yet, just like in our study, TRIO found striking geographical differences in baseline product preference [<xref rid="pone.0287525.ref040" ref-type="bibr">40</xref>].</p>
              <p>Mental health conditions, especially depression, have been shown to negatively affect adherence to oral PrEP, as well as ART initiation and continuation [<xref rid="pone.0287525.ref016" ref-type="bibr">16</xref>]. Data from our study suggests that nearly a third of participants had depressive symptoms according to the CESD-10 and an additional two-thirds had scores suggestive of alcohol abuse, which has also been shown to negatively affect adherence [<xref rid="pone.0287525.ref041" ref-type="bibr">41</xref>]. These high scores on both depressive symptoms and alcohol abuse point to the need for integration of mental health care into HIV prevention services for AGYW. Integration of these services has the potential not only to improve mental health but also could improve persistence on PrEP. Over 40% of participants had some worries about HIV acquisition, with a quarter reporting being very worried. Yet, substantial variations were found, and in some sites such as Kampala, most were not worried at all. Clear awareness of the potential for HIV transmission has been linked to high oral PrEP adherence observed in studies of HIV serodifferent couples [<xref rid="pone.0287525.ref042" ref-type="bibr">42</xref>]; conversely, low risk perceptions have been associated with poor oral PrEP uptake and continuation [<xref rid="pone.0287525.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0287525.ref044" ref-type="bibr">44</xref>]. It is therefore important to reframe HIV prevention messaging and steer away from a risk-framed message that is stigmatizing and use more empowering messaging for HIV prevention around health optimization, which are more effective [<xref rid="pone.0287525.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0287525.ref046" ref-type="bibr">46</xref>].</p>
              <p>Disclosure of study products use reduces PrEP stigma and opposition, thereby improving adherence [<xref rid="pone.0287525.ref047" ref-type="bibr">47</xref>]. Notably, the ASPIRE study showed that there is a need to go beyond disclosure to providing support to avert opposition to product use after disclosure, for example through counselling and support groups [<xref rid="pone.0287525.ref048" ref-type="bibr">48</xref>]. In REACH, most participants had disclosed their intention to use PrEP products to female family members and primary sex partners prior to initiation, but not to male family members. In the VOICE-C study, male partners of study participants reported that they were more likely to support product use by their partners if they knew more about study participation and product use [<xref rid="pone.0287525.ref049" ref-type="bibr">49</xref>], and voluntary ring removals were associated with male partner concerns in the ASPIRE study [<xref rid="pone.0287525.ref033" ref-type="bibr">33</xref>]. Even though these products are designed for women’s use, there is a need to use innovative strategies to support women in making decisions about whether to disclose to male partners and family members. More product disclosure has the potential to help AGYW gain partner support and increase acceptance of product use more broadly. This can be achieved through couple counseling, face-to-face interactions with clinicians and service providers, and community education, which could translate to more community acceptance and effective use of prevention products [<xref rid="pone.0287525.ref050" ref-type="bibr">50</xref>].</p>
              <p>This work has several limitations. Firstly, this study assessed cross sectionally stated preferences of prevention products at baseline before they had experienced using them. Future analysis from REACH will report informed preferences. Secondly our findings can only be generalizable to a narrow age group of AGYW aged 16–21, and to only two PrEP products; relative preferences for prevention products could differ for other age groups and as prevention options expand. Furthermore, the small sample size limited our ability to detect significant associations between baseline characteristics and product preferences. Thirdly, oral PrEP was already available in study countries when the trial began, whereas the ring was still under review by the regulatory authorities. It is possible that AGYW were more familiar with oral PrEP than the ring and that some participants had actually used PrEP before the trial, although this was not measured. These differences may have impacted initial responses. Despite these limitations, we were able to recruit a large proportion of minors [accompanied with parental consent], who were included for the first time in a ring trial, which will provide important safety, adherence and preference data for oral PrEP and the ring.</p>
              <p>In conclusion, baseline data for REACH indicates that our cohort had important biological and behavioral vulnerability to HIV and thus an ongoing need for effective HIV prevention strategies. Additionally, a significant proportion of the AGYW exhibited low HIV risk perception and exhibited characteristics that have been shown to affect HIV prevention product adherence, such as depressive symptoms, alcohol abuse and lack of disclosure to partners. The balanced preference between the ring and oral PrEP suggests that multiple biomedical prevention options may be appealing to this age group and could address their prevention needs. Therefore, the REACH study is poised to provide important safety and adherence data among AGYW paving way for rollout of multiple PrEP options for this population.</p>
            </sec>
            <sec id="sec017" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0287525.s001" position="float" content-type="local-data">
                <label>S1 File</label>
                <caption>
                  <title>Inclusivity in global research.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0287525.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We would like to acknowledge all trial participants for taking time to contribute to this research. Additionally, we would like to acknowledge all the research staff at the at four sites (Cape Town and Johannesburg, South Africa; Kampala, Uganda; and Harare, Zimbabwe).</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0287525.ref001">
                <label>1</label>
                <mixed-citation publication-type="other">Global HIV &amp; AIDS statistics — 2020 fact sheet <ext-link xlink:href="https://www.unaids.org/en/resources/fact-sheet" ext-link-type="uri">https://www.unaids.org/en/resources/fact-sheet</ext-link> - Accessed on November 20, 2021</mixed-citation>
              </ref>
              <ref id="pone.0287525.ref002">
                <label>2</label>
                <mixed-citation publication-type="other">UNAIDS. Women and HIV: a spotlight on adolescent girls and young women. UNAIDS. 2019. <ext-link xlink:href="https://www.unaids.org/en/resources/documents/2019/women-and-hiv" ext-link-type="uri">https://www.unaids.org/en/resources/documents/2019/women-and-hiv</ext-link> Accessed on November 20, 2021</mixed-citation>
              </ref>
              <ref id="pone.0287525.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Karim</surname><given-names>QA</given-names></name>, <name><surname>Baxter</surname><given-names>C</given-names></name>, <name><surname>Birx</surname><given-names>D</given-names></name>. <article-title>Prevention of HIV in adolescent girls and young women: key to an AIDS-free generation</article-title>. <source>JAIDS Journal of Acquired Immune Deficiency Syndromes</source>. <year>2017</year><month>May</month><day>1</day>;<volume>75</volume>: <fpage>S17</fpage>–<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/QAI.0000000000001316</pub-id>
<?supplied-pmid 28398993?><pub-id pub-id-type="pmid">28398993</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Dellar</surname><given-names>RC</given-names></name>, <name><surname>Dlamini</surname><given-names>S</given-names></name>, <name><surname>Karim</surname><given-names>QA</given-names></name>. <article-title>Adolescent girls and young women: key populations for HIV epidemic control</article-title>. <source>Journal of the International AIDS Society</source>. <year>2015</year><month>Feb</month>; <volume>18</volume>:<fpage>19408</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7448/IAS.18.2.19408</pub-id><?supplied-pmid 25724504?><pub-id pub-id-type="pmid">25724504</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref005">
                <label>5</label>
                <mixed-citation publication-type="other">Gilead Sciences, Inc. U.S. Food and Drug Administration Approves Gilead’s Truvada for Reducing the Risk of Acquiring HIV (Press Release). July 16, 2012. <ext-link xlink:href="http://www.gilead.com/news/press-releases/2012/7/us-food-and-drugadministration-approves-gileads-truvada-for-reducing-the-risk-of-acquiring-hiv" ext-link-type="uri">http://www.gilead.com/news/press-releases/2012/7/us-food-and-drugadministration-approves-gileads-truvada-for-reducing-the-risk-of-acquiring-hiv</ext-link>.)</mixed-citation>
              </ref>
              <ref id="pone.0287525.ref006">
                <label>6</label>
                <mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>WHO technical update on pre-exposure prophylaxis (PrEP)</source>. <publisher-name>World Health Organization</publisher-name>; <year>2015</year>.</mixed-citation>
              </ref>
              <ref id="pone.0287525.ref007">
                <label>7</label>
                <mixed-citation publication-type="other">World Health Organization. Department of HIV/AIDS. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach – 2nd edition. June 2016. Geneva, Switzerland</mixed-citation>
              </ref>
              <ref id="pone.0287525.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Fonner</surname><given-names>VA</given-names></name>, <name><surname>Dalglish</surname><given-names>SL</given-names></name>, <name><surname>Kennedy</surname><given-names>CE</given-names></name>, <name><surname>Baggaley</surname><given-names>R</given-names></name>, <name><surname>O’reilly</surname><given-names>KR</given-names></name>, <name><surname>Koechlin</surname><given-names>FM</given-names></name>, <etal>et al</etal>. <article-title>Effectiveness and safety of oral HIV preexposure prophylaxis for all populations</article-title>. <source>AIDS (London, England)</source>. <year>2016</year><month>Jul</month><day>31</day>;<volume>30</volume>(<issue>12</issue>): <fpage>1973</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/QAD.0000000000001145</pub-id><?supplied-pmid 27149090?><pub-id pub-id-type="pmid">27149090</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Marrazzo</surname><given-names>JM</given-names></name>, <name><surname>Ramjee</surname><given-names>G</given-names></name>, <name><surname>Richardson</surname><given-names>BA</given-names></name>, <etal>et al</etal>. <article-title>Tenofovir-based preexposure prophylaxis for HIV infection among African women</article-title>. <source>N Engl J Med</source><year>2015</year>; <volume>372</volume>(<issue>6</issue>): <fpage>509</fpage>–<lpage>18</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa1402269</pub-id>
<?supplied-pmid 25651245?><pub-id pub-id-type="pmid">25651245</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Van Damme</surname><given-names>L</given-names></name>, <name><surname>Corneli</surname><given-names>A</given-names></name>, <name><surname>Ahmed</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Preexposure prophylaxis for HIV infection among African women</article-title>. <source>N Engl J Med</source><year>2012</year>; <volume>367</volume>(<issue>5</issue>): <fpage>411</fpage>–<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa1202614</pub-id>
<?supplied-pmid 22784040?><pub-id pub-id-type="pmid">22784040</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Baeten</surname><given-names>JM</given-names></name>, <name><surname>Palanee-Phillips</surname><given-names>T</given-names></name>, <name><surname>Brown</surname><given-names>ER</given-names></name>, <name><surname>Schwartz</surname><given-names>K</given-names></name>, <name><surname>Soto-Torres</surname><given-names>LE</given-names></name>, <name><surname>Govender</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Use of a vaginal ring containing dapivirine for HIV-1 prevention in women</article-title>. <source>New England Journal of Medicine</source>. <year>2016</year><month>Dec</month><day>1</day>;<volume>375</volume>(<issue>22</issue>):<fpage>2121</fpage>–<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa1506110</pub-id>
<?supplied-pmid 26900902?><pub-id pub-id-type="pmid">26900902</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Nel</surname><given-names>A</given-names></name>, <name><surname>van Niekerk</surname><given-names>N</given-names></name>, <name><surname>Kapiga</surname><given-names>S</given-names></name>, <name><surname>Bekker</surname><given-names>LG</given-names></name>, <name><surname>Gama</surname><given-names>C</given-names></name>, <name><surname>Gill</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women</article-title>. <source>New England Journal of Medicine</source>. <year>2016</year><month>Dec</month><day>1</day>;<volume>375</volume>(<issue>22</issue>):<fpage>2133</fpage>–<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa1602046</pub-id>
<?supplied-pmid 27959766?><pub-id pub-id-type="pmid">27959766</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref013">
                <label>13</label>
                <mixed-citation publication-type="other">
                  <ext-link xlink:href="https://www.ema.europa.eu/en/news/vaginal-ring-reduce-risk-hiv-infection-women-non-eu-countries-high-disease-burden" ext-link-type="uri">https://www.ema.europa.eu/en/news/vaginal-ring-reduce-risk-hiv-infection-women-non-eu-countries-high-disease-burden</ext-link>
                </mixed-citation>
              </ref>
              <ref id="pone.0287525.ref014">
                <label>14</label>
                <mixed-citation publication-type="other">Https://<ext-link xlink:href="http://www.who.int/news/item/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection" ext-link-type="uri">www.who.int/news/item/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Brown</surname><given-names>ER</given-names></name>, <name><surname>Hendrix</surname><given-names>CW</given-names></name>, <name><surname>van der Straten</surname><given-names>A</given-names></name>, <name><surname>Kiweewa</surname><given-names>FM</given-names></name>, <name><surname>Mgodi</surname><given-names>NM</given-names></name>, <name><surname>Palanee‐Philips</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial</article-title>. <source>Journal of the International AIDS Society</source>. <year>2020</year><month>Nov</month>;<volume>23</volume>(<issue>11</issue>): <fpage>e25634</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jia2.25634</pub-id><?supplied-pmid 33206462?><pub-id pub-id-type="pmid">33206462</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Collins</surname><given-names>PY</given-names></name>, <name><surname>Velloza</surname><given-names>J</given-names></name>, <name><surname>Concepcion</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Intervening for HIV prevention and mental health: a review of global literature</article-title>. <source>J Int AIDS Soc</source>. <year>2021</year>;<volume>24</volume>(<issue>S2</issue>):<fpage>4</fpage>–<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jia2.25710</pub-id>
<?supplied-pmid 34164934?><pub-id pub-id-type="pmid">34164934</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Andresen</surname><given-names>EM</given-names></name>, <name><surname>Malmgren</surname><given-names>JA</given-names></name>, <name><surname>Carter</surname><given-names>WB</given-names></name>, <name><surname>Patrick</surname><given-names>DL</given-names></name>. <article-title>Screening for depression in well older adults: Evaluation of a short form of the CES-D</article-title>. <source>American journal of preventive medicine</source>. <year>1994</year><month>Mar</month><day>1</day>;<volume>10</volume>(<issue>2</issue>):<fpage>77</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">8037935</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Baron</surname><given-names>EC</given-names></name>, <name><surname>Davies</surname><given-names>T</given-names></name>, <name><surname>Lund</surname><given-names>C</given-names></name>. <article-title>Validation of the 10-item centre for epidemiological studies depression scale (CES-D-10) in Zulu, Xhosa and Afrikaans populations in South Africa</article-title>. <source>BMC psychiatry</source>. <year>2017</year><month>Dec</month>;<volume>17</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">28049496</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>NA</given-names></name>, <name><surname>Kypri</surname><given-names>K</given-names></name>, <name><surname>Saunders</surname><given-names>JB</given-names></name>, <name><surname>Saitz</surname><given-names>R</given-names></name>, <name><surname>Attia</surname><given-names>J</given-names></name>, <name><surname>Latter</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Effect of electronic screening and brief intervention on hazardous or harmful drinking among adults in the hospital outpatient setting: A randomized, double-blind, controlled trial</article-title>. <source>Drug and alcohol dependence</source>. <year>2018</year><month>Oct</month><day>1</day>; <volume>191</volume>:<fpage>78</fpage>–<lpage>85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2018.06.030</pub-id>
<?supplied-pmid 30096637?><pub-id pub-id-type="pmid">30096637</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Morean</surname><given-names>ME</given-names></name>, <name><surname>DeMartini</surname><given-names>KS</given-names></name>, <name><surname>Leeman</surname><given-names>RF</given-names></name>, <name><surname>Pearlson</surname><given-names>GD</given-names></name>, <name><surname>Anticevic</surname><given-names>A</given-names></name>, <name><surname>Krishnan-Sarin</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Psychometrically improved, abbreviated versions of three classic measures of impulsivity and self-control</article-title>. <source>Psychological assessment</source>. <year>2014</year><month>Sep</month>;<volume>26</volume>(<issue>3</issue>):<fpage>1003</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/pas0000003</pub-id><?supplied-pmid 24885848?><pub-id pub-id-type="pmid">24885848</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Zimet</surname><given-names>G.D.</given-names></name>, <name><surname>Dahlem</surname><given-names>N. W.</given-names></name>, <name><surname>Zimet</surname><given-names>S. G.</given-names></name>, <etal>et al</etal>., <article-title>The multidimensional scale of perceived social support</article-title>. <source>Journal of Personality Assessment</source>, <year>1988</year>. <volume>52</volume>(<issue>1</issue>): p. <fpage>30</fpage>–<lpage>41</lpage></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Nakigudde</surname><given-names>Janet</given-names></name>, <name><surname>Musisi</surname><given-names>Seggane</given-names></name>, <name><surname>Ehnvall</surname><given-names>Anna</given-names></name>, <name><surname>Airaksinen</surname><given-names>Eija</given-names></name>, <name><surname>Agren</surname><given-names>Hans</given-names></name>. <article-title>Adaptation of the multidimensional scale of perceived social support in a Ugandan setting</article-title>. <source>African Health Sciences</source><year>2009</year>; <volume>9</volume>(<issue>S1</issue>): <fpage>35</fpage>–<lpage>41</lpage></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Bruwera</surname><given-names>Belinda</given-names></name>, <name><surname>Emsleya</surname><given-names>Robin</given-names></name>, <name><surname>Kiddb</surname><given-names>Martin</given-names></name>, <name><surname>Lochnerc</surname><given-names>Christine</given-names></name>, <name><surname>Seedat</surname><given-names>Soraya</given-names></name>. <source>Psychometric properties of the Multidimensional Scale of Perceived Social Support in youth Comprehensive Psychiatry</source><volume>49</volume> (<year>2008</year>) <fpage>195</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">18243894</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Francis</surname><given-names>SC</given-names></name>, <name><surname>Mthiyane</surname><given-names>TN</given-names></name>, <name><surname>Baisley</surname><given-names>K</given-names></name>, <name><surname>Mchunu</surname><given-names>SL</given-names></name>, <name><surname>Ferguson</surname><given-names>JB</given-names></name>, <name><surname>Smit</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site</article-title>. <source>PLoS Med</source>. (<year>2018</year>) <volume>15</volume>:<fpage>e1002512</fpage> 10.1371/journal.pmed.1002512 <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1002512</pub-id>
<?supplied-pmid 29485985?><pub-id pub-id-type="pmid">29485985</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Yuh</surname><given-names>T</given-names></name>, <name><surname>Micheni</surname><given-names>M</given-names></name>, <name><surname>Selke</surname><given-names>S</given-names></name>, <name><surname>Oluoch</surname><given-names>L</given-names></name>, <name><surname>Kiptinness</surname><given-names>C</given-names></name>, <name><surname>Magaret</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Sexually transmitted infections among Kenyan adolescent girls and young women with limited sexual experience</article-title>. <source>Frontiers in Public Health</source>. <year>2020</year><month>Jul</month><day>14</day>;<volume>8</volume>:<fpage>303</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fpubh.2020.00303</pub-id><?supplied-pmid 32766197?><pub-id pub-id-type="pmid">32766197</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Kaida</surname><given-names>A</given-names></name>, <name><surname>Dietrich</surname><given-names>JJ</given-names></name>, <name><surname>Laher</surname><given-names>F</given-names></name>, <name><surname>Beksinska</surname><given-names>M</given-names></name>, <name><surname>Jaggernath</surname><given-names>M</given-names></name>, <name><surname>Bardsley</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A high burden of asymptomatic genital tract infections undermines the syndromic management approach among adolescents and young adults in South Africa: implications for HIV prevention efforts</article-title>. <source>BMC Infect Dis</source>. (<year>2018</year>) <volume>18</volume>:<fpage>499</fpage> 10.1186/s12879-018-3380-6 <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12879-018-3380-6</pub-id>
<?supplied-pmid 30285705?><pub-id pub-id-type="pmid">30285705</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Barnabas</surname><given-names>SL</given-names></name>, <name><surname>Dabee</surname><given-names>S</given-names></name>, <name><surname>Passmore</surname><given-names>JS</given-names></name>, <name><surname>Jaspan</surname><given-names>HB</given-names></name>, <name><surname>Lewis</surname><given-names>DA</given-names></name>, <name><surname>Jaumdally</surname><given-names>SZ</given-names></name>, <etal>et al</etal>. <article-title>Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV</article-title>. <source>Int J STD AIDS</source>. (<year>2018</year>) <volume>29</volume>:<fpage>531</fpage>–<lpage>9</lpage>. 10.1177/0956462417740487 <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/0956462417740487</pub-id>
<?supplied-pmid 29198180?><pub-id pub-id-type="pmid">29198180</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Masese</surname><given-names>LN</given-names></name>, <name><surname>Wanje</surname><given-names>G</given-names></name>, <name><surname>Kabare</surname><given-names>E</given-names></name>, <name><surname>Budambula</surname><given-names>V</given-names></name>, <name><surname>Mutuku</surname><given-names>F</given-names></name>, <name><surname>Omoni</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Screening for sexually transmitted infections in adolescent girls and young women in Mombasa, Kenya: feasibility, prevalence, and correlates</article-title>. <source>Sex Transm Dis</source>. (<year>2017</year>) <volume>44</volume>:<fpage>725</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/OLQ.0000000000000674</pub-id>
<?supplied-pmid 28876312?><pub-id pub-id-type="pmid">28876312</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Rigby</surname><given-names>SW</given-names></name>, <name><surname>Johnson</surname><given-names>LF</given-names></name>. <article-title>The relationship between intimate partner violence and HIV: A model-based evaluation</article-title>. <source>Infectious Disease Modelling</source>. <year>2017</year><month>Feb</month><day>1</day>;<volume>2</volume>(<issue>1</issue>):<fpage>71</fpage>–<lpage>89</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.idm.2017.02.002</pub-id>
<?supplied-pmid 29928730?><pub-id pub-id-type="pmid">29928730</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Celum</surname><given-names>C</given-names></name>, <name><surname>Mgodi</surname><given-names>N</given-names></name>, <name><surname>Bekker</surname><given-names>LG</given-names></name>, <name><surname>Hosek</surname><given-names>S</given-names></name>, <name><surname>Donnel</surname><given-names>D</given-names></name>, <name><surname>Anderson</surname><given-names>P</given-names></name>. <article-title>PrEP use in young African women in HPTN 082: effect of drug level feedback. In: 10th IAS Conference on HIV Science</article-title>. <source>Mexico City</source> (<year>2019</year>).</mixed-citation>
              </ref>
              <ref id="pone.0287525.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Gill</surname><given-names>K</given-names></name>, <name><surname>Johnson</surname><given-names>L</given-names></name>, <name><surname>Dietrich</surname><given-names>J</given-names></name>, <name><surname>Myer</surname><given-names>L</given-names></name>, <name><surname>Marcus</surname><given-names>R</given-names></name>, <name><surname>Wallace</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial</article-title>. <source>Lancet Child Adolesc Health</source>. (<year>2020</year>) <volume>4</volume>:<fpage>875</fpage>–<lpage>83</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2352-4642(20)30248-0</pub-id>
<?supplied-pmid 33222803?><pub-id pub-id-type="pmid">33222803</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Haberer</surname><given-names>JE</given-names></name>, <name><surname>Bukusi</surname><given-names>EA</given-names></name>, <name><surname>Mugo</surname><given-names>NR</given-names></name>, <name><surname>Pyra</surname><given-names>M</given-names></name>, <name><surname>Kiptinness</surname><given-names>C</given-names></name>, <name><surname>Oware</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial</article-title>. <source>Lancet HIV</source>. (<year>2021</year>) <volume>8</volume>: <fpage>e130</fpage>–<lpage>e7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2352-3018(20)30307-6</pub-id>
<?supplied-pmid 33662265?><pub-id pub-id-type="pmid">33662265</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Montgomery</surname><given-names>ET</given-names></name>, <name><surname>van der Straten</surname><given-names>A</given-names></name>, <name><surname>Chitukuta</surname><given-names>M</given-names></name>, <name><surname>Reddy</surname><given-names>K</given-names></name>, <name><surname>Woeber</surname><given-names>K</given-names></name>, <name><surname>Atujuna</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Acceptability and use of a dapivirine vaginal ring in a phase III trial</article-title>. <source>AIDS (London, England)</source>. <year>2017</year><month>May</month><day>15</day>;<volume>31</volume>(<issue>8</issue>):<fpage>1159</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/QAD.0000000000001452</pub-id><?supplied-pmid 28441175?><pub-id pub-id-type="pmid">28441175</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Van der Straten</surname><given-names>A</given-names></name>, <name><surname>Agot</surname><given-names>K</given-names></name>, <name><surname>Ahmed</surname><given-names>K</given-names></name>, <name><surname>Weinrib</surname><given-names>R</given-names></name>, <name><surname>Browne</surname><given-names>EN</given-names></name>, <name><surname>Manenzhe</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention</article-title>. <source>Journal of the International AIDS Society</source>. <year>2018</year><month>Mar</month>;<volume>21</volume>(<issue>3</issue>):<fpage>e25094</fpage>.” <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jia2.25094</pub-id>
<?supplied-pmid 29600595?><pub-id pub-id-type="pmid">29600595</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Luecke</surname><given-names>EH</given-names></name>, <name><surname>Cheng</surname><given-names>H</given-names></name>, <name><surname>Woeber</surname><given-names>K</given-names></name>, <name><surname>Nakyanzi</surname><given-names>T</given-names></name>, <name><surname>Mudekunye‐Mahaka</surname><given-names>IC</given-names></name>, <name><surname>van der Straten</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Stated product formulation preferences for HIV pre‐exposure prophylaxis among women in the VOICE‐D (MTN‐003D) study</article-title>. <source>Journal of the International AIDS Society</source>. <year>2016</year><month>Jan</month>;<volume>19</volume>(<issue>1</issue>):<fpage>20875</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7448/IAS.19.1.20875</pub-id><?supplied-pmid 27247202?><pub-id pub-id-type="pmid">27247202</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Mayo</surname><given-names>AJ</given-names></name>, <name><surname>Browne</surname><given-names>EN</given-names></name>, <name><surname>Montgomery</surname><given-names>ET</given-names></name>, <name><surname>Torjesen</surname><given-names>K</given-names></name>, <name><surname>Palanee-Phillips</surname><given-names>T</given-names></name>, <name><surname>Jeenarain</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial</article-title>. <source>AIDS and Behavior</source>. <year>2021</year><month>Aug</month>;<volume>25</volume>(<issue>8</issue>):<fpage>2430</fpage>–<lpage>40</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10461-021-03205-z</pub-id>
<?supplied-pmid 33713213?><pub-id pub-id-type="pmid">33713213</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Minnis</surname><given-names>AM</given-names></name>, <name><surname>Gandham</surname><given-names>S</given-names></name>, <name><surname>Richardson</surname><given-names>BA</given-names></name>, <name><surname>Guddera</surname><given-names>V</given-names></name>, <name><surname>Chen</surname><given-names>BA</given-names></name>, <name><surname>Salata</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women</article-title>. <source>AIDS and Behavior</source>. <year>2013</year><month>Feb</month>;<volume>17</volume>(<issue>2</issue>):<fpage>737</fpage>–<lpage>47</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10461-012-0333-8</pub-id>
<?supplied-pmid 23065145?><pub-id pub-id-type="pmid">23065145</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Tolley</surname><given-names>EE</given-names></name>, <name><surname>Zangeneh</surname><given-names>SZ</given-names></name>, <name><surname>Chau</surname><given-names>G</given-names></name>, <name><surname>Eron</surname><given-names>J</given-names></name>, <name><surname>Grinsztejn</surname><given-names>B</given-names></name>, <name><surname>Humphries</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Acceptability of long-acting injectable cabotegravir (CAB LA) in HIV-uninfected individuals: HPTN 077</article-title>. <source>AIDS and Behavior</source>. <year>2020</year><month>Sep</month>;<volume>24</volume>(<issue>9</issue>):<fpage>2520</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10461-020-02808-2</pub-id>
<?supplied-pmid 32052214?><pub-id pub-id-type="pmid">32052214</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Ngure</surname><given-names>K</given-names></name>, <name><surname>Mugo</surname><given-names>NR</given-names></name>, <name><surname>Bukusi</surname><given-names>EA</given-names></name>, <name><surname>Kiptinness</surname><given-names>C</given-names></name>, <name><surname>Oware</surname><given-names>K</given-names></name>, <name><surname>Gakuo</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Pills, Injections, Rings, or Implants? PrEP Formulation Preferences of PrEP-Experienced African Women for HIV Prevention</article-title>. <source>JAIDS Journal of Acquired Immune Deficiency Syndromes</source>. <year>2021</year><month>Dec</month><day>1</day>;<volume>88</volume>(<issue>4</issue>): <fpage>e30</fpage>–<lpage>2</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/QAI.0000000000002793</pub-id>
<?supplied-pmid 34446676?><pub-id pub-id-type="pmid">34446676</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Weinrib</surname><given-names>R</given-names></name>, <name><surname>Minnis</surname><given-names>A</given-names></name>, <name><surname>Agot</surname><given-names>K</given-names></name>, <name><surname>Ahmed</surname><given-names>K</given-names></name>, <name><surname>Owino</surname><given-names>F</given-names></name>, <name><surname>Manenzhe</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>End-users’ product preference across three multipurpose prevention technology delivery forms: baseline results from young women in Kenya and South Africa</article-title>. <source>AIDS and Behavior</source>. <year>2018</year><month>Jan</month>;<volume>22</volume>(<issue>1</issue>):<fpage>133</fpage>–<lpage>45</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10461-017-1911-6</pub-id>
<?supplied-pmid 29052018?><pub-id pub-id-type="pmid">29052018</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Celum</surname><given-names>CL</given-names></name>, <name><surname>Delany‐Moretlwe</surname><given-names>S</given-names></name>, <name><surname>Baeten</surname><given-names>JM</given-names></name>, <name><surname>van der Straten</surname><given-names>A</given-names></name>, <name><surname>Hosek</surname><given-names>S</given-names></name>, <name><surname>Bukusi</surname><given-names>EA</given-names></name>, <etal>et al</etal>. <article-title>HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery</article-title>. <source>Journal of the International AIDS Society</source>. <year>2019</year><month>Jul</month>;<volume>22</volume>: <fpage>e25298</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jia2.25298</pub-id><?supplied-pmid 31328444?><pub-id pub-id-type="pmid">31328444</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Haberer</surname><given-names>JE</given-names></name>, <name><surname>Ngure</surname><given-names>K</given-names></name>, <name><surname>Muwonge</surname><given-names>T</given-names></name>, <name><surname>Mugo</surname><given-names>N</given-names></name>, <name><surname>Katabira</surname><given-names>E</given-names></name>, <name><surname>Heffron</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Context matters: PrEP adherence is associated with sexual behavior among HIV serodiscordant couples in East Africa</article-title>. <source>J Acquir Immune Defic Syndr</source>. (<year>2017</year>) <volume>76</volume>:<fpage>488</fpage>–<lpage>92</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/QAI.0000000000001548</pub-id><pub-id pub-id-type="pmid">28961676</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Kohler</surname><given-names>PK</given-names></name>, <etal>et al</etal>. <article-title>High awareness, yet low uptake, of pre-exposure prophylaxis among adolescent girls and young women within family planning clinics in Kenya</article-title>. <source>AIDS Patient Care STDs</source>. (<year>2020</year>) <volume>34</volume>:<fpage>336</fpage>–<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1089/apc.2020.0037</pub-id>
<?supplied-pmid 32757980?><pub-id pub-id-type="pmid">32757980</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Oluoch</surname><given-names>LM</given-names></name>, <name><surname>Roxby</surname><given-names>A</given-names></name>, <name><surname>Mugo</surname><given-names>N</given-names></name>, <name><surname>Wald</surname><given-names>A</given-names></name>, <name><surname>Ngure</surname><given-names>K</given-names></name>, <name><surname>Selke</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Does providing laboratory confirmed STI results impact uptake of HIV pre-exposure prophylaxis (PrEP) uptake among Kenyan adolescents girls and young women? A descriptive analysis</article-title>. <source>Sex Trans Infect</source>. (<year>2020</year>). [Epub ahead of print]. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/sextrans-2020-054637</pub-id><?supplied-pmid 32917766?><pub-id pub-id-type="pmid">32917766</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Haberer</surname><given-names>JE</given-names></name>, <name><surname>Mugo</surname><given-names>N</given-names></name>, <name><surname>Baeten</surname><given-names>JM</given-names></name>, <name><surname>Pyra</surname><given-names>M</given-names></name>, <name><surname>Bukusi</surname><given-names>E</given-names></name>, <name><surname>Bekker</surname><given-names>LG</given-names></name>. <article-title>PrEP as a lifestyle and investment for adolescent girls and young women in Sub-Saharan Africa</article-title>. <source>J Int Assoc Provid AIDS Care</source>. <year>2019</year>; <volume>18</volume>:2325958219831011 <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/2325958219831011</pub-id><?supplied-pmid 30776954?><pub-id pub-id-type="pmid">30776954</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Amico</surname><given-names>KR</given-names></name>, <name><surname>Bekker</surname><given-names>LG</given-names></name>. <article-title>Global PrEP roll-out: recommendations for programmatic success</article-title>. <source>Lancet HIV</source>. <year>2019</year>;<volume>6</volume>(<issue>2</issue>): <fpage>e137</fpage>–<lpage>e140140</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2352-3018(19)30002-5</pub-id>
<?supplied-pmid 30660592?><pub-id pub-id-type="pmid">30660592</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Velloza</surname><given-names>J</given-names></name>, <name><surname>Khoza</surname><given-names>N</given-names></name>, <name><surname>Scorgie</surname><given-names>F</given-names></name>, <name><surname>Chitukuta</surname><given-names>M</given-names></name>, <name><surname>Mutero</surname><given-names>P</given-names></name>, <name><surname>Mutiti</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study</article-title>. <source>Journal of the International AIDS Society</source>. <year>2020</year><month>Mar</month>;<volume>23</volume>(<issue>3</issue>):<fpage>e25463</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jia2.25463</pub-id><?supplied-pmid 32144874?><pub-id pub-id-type="pmid">32144874</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Roberts</surname><given-names>ST</given-names></name>, <name><surname>Nair</surname><given-names>G</given-names></name>, <name><surname>Baeten</surname><given-names>JM</given-names></name>, <name><surname>Palanee-Philips</surname><given-names>T</given-names></name>, <name><surname>Schwartz</surname><given-names>K</given-names></name>, <name><surname>Reddy</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Impact of male partner involvement on women’s adherence to the dapivirine vaginal ring during a phase III HIV prevention trial</article-title>. <source>AIDS and Behavior</source>. <year>2020</year><month>May</month>;<volume>24</volume>(<issue>5</issue>):<fpage>1432</fpage>–<lpage>42</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10461-019-02707-1</pub-id>
<?supplied-pmid 31667678?><pub-id pub-id-type="pmid">31667678</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Montgomery</surname><given-names>ET</given-names></name>, <name><surname>van der Straten</surname><given-names>A</given-names></name>, <name><surname>Stadler</surname><given-names>J</given-names></name>, <name><surname>Hartmann</surname><given-names>M</given-names></name>, <name><surname>Magazi</surname><given-names>B</given-names></name>, <name><surname>Mathebula</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Male partner influence on women’s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of “understanding</article-title>”. <source>AIDS and Behavior</source>. <year>2015</year>
<month>May</month>;<volume>19</volume>(<issue>5</issue>):<fpage>784</fpage>–<lpage>93</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10461-014-0950-5</pub-id>
<?supplied-pmid 25416076?><pub-id pub-id-type="pmid">25416076</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0287525.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Montgomery</surname><given-names>ET</given-names></name>, <name><surname>Roberts</surname><given-names>ST</given-names></name>, <name><surname>Reddy</surname><given-names>K</given-names></name>, <name><surname>Tolley</surname><given-names>E</given-names></name>, <name><surname>Hartmann</surname><given-names>M</given-names></name>, <name><surname>Wilson</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study</article-title>. <source>AIDS and Behavior</source>. <year>2021</year><month>Sep</month><volume>21</volume>:<fpage>1</fpage>–<lpage>2</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10461-021-03434-2</pub-id>
<?supplied-pmid 34546473?><pub-id pub-id-type="pmid">34546473</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
